https://www.medxy.ai/news/dapivirine-ring-safety 2026-02-14T21:16:03.000Z daily 0.75 https://www.medxy.ai/news/vi/dapivirine-vaginal-ring-safe 2026-02-18T18:29:51.000Z daily 0.75 https://www.medxy.ai/news/ja/safety-of-dapivirine-prep 2026-02-18T18:29:42.000Z daily 0.75 https://www.medxy.ai/news/zh/deliver-study-safety-prenatal 2026-02-18T18:29:34.000Z daily 0.75 https://www.medxy.ai/news/recombinant-zoster-vaccine-safety 2026-02-15T11:46:27.000Z daily 0.75 https://www.medxy.ai/news/vi/vaccine-herpes-zoster-safety 2026-02-18T18:29:23.000Z daily 0.75 https://www.medxy.ai/news/ja/recombinant-herpes-vaccine-safety 2026-02-18T18:29:11.000Z daily 0.75 https://www.medxy.ai/news/zh/shingles-vaccine-safety 2026-02-18T18:28:56.000Z daily 0.75 https://www.medxy.ai/news/obesity-infection-risk 2026-02-15T19:30:16.000Z daily 0.75 https://www.medxy.ai/news/vi/obesity-increases-infection-risk 2026-02-18T18:28:39.000Z daily 0.75 https://www.medxy.ai/news/ja/obesity-infection-risk-3 2026-02-18T18:28:31.000Z daily 0.75 https://www.medxy.ai/news/zh/obesity-infection-risk-2 2026-02-18T18:28:23.000Z daily 0.75 https://www.medxy.ai/news/delirium-sentinel-event 2026-02-15T23:29:56.000Z daily 0.75 https://www.medxy.ai/news/vi/disorder-alert-syndrome 2026-02-18T18:26:53.000Z daily 0.75 https://www.medxy.ai/news/ja/delirium-sentinel-event-3 2026-02-18T18:26:44.000Z daily 0.75 https://www.medxy.ai/news/zh/delirium-sentinel-event-2 2026-02-18T18:26:35.000Z daily 0.75 https://www.medxy.ai/news/doravirine-islatravir-hiv-maintenance 2026-02-15T23:47:02.000Z daily 0.75 https://www.medxy.ai/news/vi/doravirine-islatravir-hiv 2026-02-18T18:26:20.000Z daily 0.75 https://www.medxy.ai/news/ja/drb-islat-non-inferiority-hiv 2026-02-18T18:26:10.000Z daily 0.75 https://www.medxy.ai/news/zh/dola-etrovir-islatravir-hiv 2026-02-18T18:26:03.000Z daily 0.75 https://www.medxy.ai/news/selective-trpc6-inhibition 2026-02-16T07:56:11.000Z daily 0.75 https://www.medxy.ai/news/vi/trpc6-treatment-model 2026-02-18T18:25:51.000Z daily 0.75 https://www.medxy.ai/news/ja/trpc6-inhibitor-new-therapy 2026-02-18T18:25:42.000Z daily 0.75 https://www.medxy.ai/news/zh/selective-trpc6-inhibitors 2026-02-18T18:25:34.000Z daily 0.75 https://www.medxy.ai/news/surgical-fixation-pediatric-fractures 2026-02-16T09:07:37.000Z daily 0.75 https://www.medxy.ai/news/vi/surgery-not-beneficial-for-fractures 2026-02-18T18:25:20.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-elbow-fracture-surgery 2026-02-18T18:25:08.000Z daily 0.75 https://www.medxy.ai/news/zh/surgical-fixation-ineffective 2026-02-18T18:24:57.000Z daily 0.75 https://www.medxy.ai/news/systematic-complication-management-pancreatic-cancer 2026-02-16T09:15:23.000Z daily 0.75 https://www.medxy.ai/news/vi/pancreatic-cancer-survival-insights 2026-02-18T18:24:43.000Z daily 0.75 https://www.medxy.ai/news/ja/systematic-complication-management-panceratic-cancer 2026-02-18T18:24:34.000Z daily 0.75 https://www.medxy.ai/news/zh/systemic-complication-management-pancreatic-cancer 2026-02-18T18:24:25.000Z daily 0.75 https://www.medxy.ai/news/early-tb-prevention-hiv 2026-02-16T09:33:45.000Z daily 0.75 https://www.medxy.ai/news/vi/early-launch-tuberculosis-prevention 2026-02-18T18:24:09.000Z daily 0.75 https://www.medxy.ai/news/zh/early-tb-treatment-non-inferior 2026-02-18T18:23:46.000Z daily 0.75 https://www.medxy.ai/news/physiological-recovery-lags 2026-02-16T14:08:30.000Z daily 0.75 https://www.medxy.ai/news/vi/beyond-symptoms-recovery-covid-flu 2026-02-18T18:23:27.000Z daily 0.75 https://www.medxy.ai/news/ja/symptoms-and-recovery 2026-02-18T18:23:11.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-symptom-relief 2026-02-18T18:23:02.000Z daily 0.75 https://www.medxy.ai/news/tenecteplase-basilar-occlusion 2026-02-16T15:57:43.000Z daily 0.75 https://www.medxy.ai/news/vi/tenecteplase-improves-functional-outcomes 2026-02-18T18:22:47.000Z daily 0.75 https://www.medxy.ai/news/ja/tenecteplase-improves-outcomes 2026-02-18T18:22:41.000Z daily 0.75 https://www.medxy.ai/news/zh/treatment-of-basilar-occlusion 2026-02-18T18:22:35.000Z daily 0.75 https://www.medxy.ai/news/statin-adverse-effects 2026-02-16T19:28:44.000Z daily 0.75 https://www.medxy.ai/news/vi/brand-challenge-statin-side-effects 2026-02-18T18:22:21.000Z daily 0.75 https://www.medxy.ai/news/ja/label-challenge-statins-side-effects 2026-02-18T18:22:14.000Z daily 0.75 https://www.medxy.ai/news/zh/challenge-label-statins-adverse-effects 2026-02-18T18:20:47.000Z daily 0.75 https://www.medxy.ai/news/efimosfermin-safety-trial 2026-02-16T20:50:02.000Z daily 0.75 https://www.medxy.ai/news/vi/efimosfermin-alfa-safety-study 2026-02-18T18:20:39.000Z daily 0.75 https://www.medxy.ai/news/ja/efimolomab-safety-study 2026-02-18T18:20:31.000Z daily 0.75 https://www.medxy.ai/news/zh/efimosfermin-alfa-safety 2026-02-18T18:20:21.000Z daily 0.75 https://www.medxy.ai/news/rapid-remission-anifrolumab 2026-02-17T10:57:49.000Z daily 0.75 https://www.medxy.ai/news/vi/quick-response-anifrolumab-lupus 2026-02-18T18:20:06.000Z daily 0.75 https://www.medxy.ai/news/ja/rapid-remission-slel-lupus-anifrolumab 2026-02-18T18:19:51.000Z daily 0.75 https://www.medxy.ai/news/zh/rapid-relief-sle-anifrolumab 2026-02-18T18:19:44.000Z daily 0.75 https://www.medxy.ai/news/factor-vii-fails-fastest-trial 2026-02-17T13:20:56.000Z daily 0.75 https://www.medxy.ai/news/vi/factor-vii-a-recombinant 2026-02-18T18:19:28.000Z daily 0.75 https://www.medxy.ai/news/ja/factor-viia-bleeding-study 2026-02-18T18:19:19.000Z daily 0.75 https://www.medxy.ai/news/zh/recombinant-factor-viia-fastest-trial 2026-02-18T18:19:10.000Z daily 0.75 https://www.medxy.ai/news/masld-impact-india 2026-02-17T13:40:58.000Z daily 0.75 https://www.medxy.ai/news/vi/masld-impact-india-3 2026-02-18T18:18:56.000Z daily 0.75 https://www.medxy.ai/news/ja/masld-india-study 2026-02-18T18:18:45.000Z daily 0.75 https://www.medxy.ai/news/zh/masld-impact-india-2 2026-02-18T18:18:37.000Z daily 0.75 https://www.medxy.ai/news/fractionated-dosing-varnimcabtagene 2026-02-18T18:18:29.000Z daily 0.75 https://www.medxy.ai/news/vi/varnimcabtagene-autoleucel-b-all 2026-02-18T18:18:23.000Z daily 0.75 https://www.medxy.ai/news/ja/varnimcabtagene-autoleucel-dosing 2026-02-18T18:18:18.000Z daily 0.75 https://www.medxy.ai/news/zh/varnimaicai-cell-therapy-b-all 2026-02-18T18:18:06.000Z daily 0.75 https://www.medxy.ai/news/cpx-351-aml-mutations 2026-02-18T18:17:58.000Z daily 0.75 https://www.medxy.ai/news/vi/cpx-351-aml-benefits 2026-02-18T18:17:49.000Z daily 0.75 https://www.medxy.ai/news/ja/cpx-351-aml-effect 2026-02-18T18:17:38.000Z daily 0.75 https://www.medxy.ai/news/zh/cpx-351-aml-efficacy 2026-02-18T18:17:31.000Z daily 0.75 https://www.medxy.ai/news/environmental-interventions-childcare 2026-02-17T15:51:54.000Z daily 0.75 https://www.medxy.ai/news/vi/why-environmental-intervention-in-childcare-may-not-be-enough 2026-02-18T18:17:21.000Z daily 0.75 https://www.medxy.ai/news/ja/lack-of-intervention-in-nurseries 2026-02-18T18:17:13.000Z daily 0.75 https://www.medxy.ai/news/zh/why-environmental-interventions-fall-short 2026-02-18T18:17:06.000Z daily 0.75 https://www.medxy.ai/news/dementia-progression-stroke 2026-02-17T16:45:23.000Z daily 0.75 https://www.medxy.ai/news/vi/stroke-related-dementia-progression 2026-02-18T18:16:58.000Z daily 0.75 https://www.medxy.ai/news/ja/dementia-progress-prediction 2026-02-18T18:16:44.000Z daily 0.75 https://www.medxy.ai/news/zh/dementia-prediction-stroke-progress 2026-02-18T18:16:35.000Z daily 0.75 https://www.medxy.ai/news/resminostat-therapy-delays-disease 2026-02-17T17:35:59.000Z daily 0.75 https://www.medxy.ai/news/vi/resminostat-therapy-lymphoma 2026-02-18T18:16:24.000Z daily 0.75 https://www.medxy.ai/news/ja/resminostat-treatment-delays-ptcl 2026-02-18T18:16:16.000Z daily 0.75 https://www.medxy.ai/news/zh/remdesivir-delay-ctcl-progression 2026-02-18T18:16:05.000Z daily 0.75 https://www.medxy.ai/news/chronic-suffering-children 2026-02-17T19:59:45.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-chronic-pain 2026-02-18T18:15:47.000Z daily 0.75 https://www.medxy.ai/news/ja/end-of-life-issues-child-chronic-pain 2026-02-18T18:15:25.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-life-end-children-illness 2026-02-18T18:15:14.000Z daily 0.75 https://www.medxy.ai/news/ai-assistant-cns-tumor-classification 2026-02-18T09:08:46.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-assisted-cns-tumor-classification 2026-02-18T18:14:55.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-assistant-cns-tumor-classification-2 2026-02-18T18:14:46.000Z daily 0.75 https://www.medxy.ai/news/closing-the-gap-minimally-invasive-surgery 2026-02-18T09:12:55.000Z daily 0.75 https://www.medxy.ai/news/vi/minimally-invasive-surgery-colon-cancer 2026-02-18T18:14:26.000Z daily 0.75 https://www.medxy.ai/news/ja/equal-access-colon-cancer-surgery 2026-02-18T18:14:15.000Z daily 0.75 https://www.medxy.ai/news/zh/narrowing-gaps-fair-minimally-invasive-surgery 2026-02-18T18:14:04.000Z daily 0.75 https://www.medxy.ai/news/metastasis-therapy-benefits 2026-02-18T12:20:50.000Z daily 0.75 https://www.medxy.ai/news/vi/targeted-therapy-prostate-cancer 2026-02-18T18:13:51.000Z daily 0.75 https://www.medxy.ai/news/ja/prostate-cancer-treatment-2 2026-02-18T18:13:42.000Z daily 0.75 https://www.medxy.ai/news/zh/treatment-for-oligometastatic-prostate-cancer 2026-02-18T18:13:32.000Z daily 0.75 https://www.medxy.ai/news/indigenous-ancestry-diabetes 2026-02-18T12:29:31.000Z daily 0.75 https://www.medxy.ai/news/vi/indigenous-genetics-diabetes 2026-02-18T18:13:19.000Z daily 0.75 https://www.medxy.ai/news/ja/mexico-public-health-crisis 2026-02-18T18:13:03.000Z daily 0.75 https://www.medxy.ai/news/zh/amerindian-diabetes-genetics 2026-02-18T18:12:54.000Z daily 0.75 https://www.medxy.ai/news/patient-reported-outcomes-toxicity-assessments 2026-02-18T18:07:49.000Z daily 0.75 https://www.medxy.ai/news/vi/integrated-reports-reliability 2026-02-18T19:15:27.000Z daily 0.75 https://www.medxy.ai/news/ja/improving-toxicity-evaluation 2026-02-18T19:15:32.000Z daily 0.75 https://www.medxy.ai/news/zh/patient-reporting-reliability 2026-02-18T19:15:38.000Z daily 0.75 https://www.medxy.ai/news/cabozantinib-temozolomide-approach 2026-02-18T18:20:56.000Z daily 0.75 https://www.medxy.ai/news/vi/cabozantinib-temozolomide-approach-2 2026-02-18T19:15:53.000Z daily 0.75 https://www.medxy.ai/news/ja/cobimetinib-temozolomide-combination 2026-02-18T19:15:57.000Z daily 0.75 https://www.medxy.ai/news/zh/cabozantinib-temozolomide-combo 2026-02-18T19:16:03.000Z daily 0.75 https://www.medxy.ai/news/vasovagal-interventions-trial 2026-02-18T18:27:05.000Z daily 0.75 https://www.medxy.ai/news/vi/standard-prevention-measures 2026-02-18T19:16:15.000Z daily 0.75 https://www.medxy.ai/news/zh/standard-precautions-blood-donors 2026-02-18T19:16:31.000Z daily 0.75 https://www.medxy.ai/news/gynaecological-carcinoma-trial 2026-02-18T19:13:54.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-drug-resistance-cancer 2026-02-19T13:59:50.000Z daily 0.75 https://www.medxy.ai/news/personalised-t-cell-activation-mlr-disease 2026-02-19T13:59:35.000Z daily 0.75 https://www.medxy.ai/news/vi/t-cell-therapy-promise 2026-02-19T13:59:21.000Z daily 0.75 https://www.medxy.ai/news/ja/personalized-t-cell-activation 2026-02-19T13:59:15.000Z daily 0.75 https://www.medxy.ai/news/zh/personalized-t-cell-activation-2 2026-02-19T13:59:09.000Z daily 0.75 https://www.medxy.ai/news/beyond-daily-pill-hiv-treatment 2026-02-19T09:18:05.000Z daily 0.75 https://www.medxy.ai/news/aumolertinib-lung-cancer-trial 2026-02-19T09:33:02.000Z daily 0.75 https://www.medxy.ai/news/zh/ameinib-egfr-lung-cancer-trial 2026-02-19T13:58:58.000Z daily 0.75 https://www.medxy.ai/news/ja/aumolertinib-egfr-lung-cancer 2026-02-19T13:58:50.000Z daily 0.75 https://www.medxy.ai/news/redefining-reliever-therapy 2026-02-19T12:17:33.000Z daily 0.75 https://www.medxy.ai/news/vi/redefining-relief-therapy 2026-02-19T13:58:40.000Z daily 0.75 https://www.medxy.ai/news/ja/redifining-acute-care-budesonide-formoterol 2026-02-19T13:58:26.000Z daily 0.75 https://www.medxy.ai/news/zh/redefining-relief-therapy-2 2026-02-19T13:58:15.000Z daily 0.75 https://www.medxy.ai/news/cilta-cel-survival-myeloma 2026-02-19T13:57:58.000Z daily 0.75 https://www.medxy.ai/news/vi/cilta-cel-lymphoma-outcomes 2026-02-19T13:57:51.000Z daily 0.75 https://www.medxy.ai/news/ja/cilta-cel-redefines-survival 2026-02-19T13:57:45.000Z daily 0.75 https://www.medxy.ai/news/zh/cilta-cel-survival-myeloma-2 2026-02-19T13:57:38.000Z daily 0.75 https://www.medxy.ai/news/hiv-burden-gaps-iran 2026-02-19T13:11:39.000Z daily 0.75 https://www.medxy.ai/news/vi/hiv-care-issues-iran 2026-02-19T13:57:30.000Z daily 0.75 https://www.medxy.ai/news/ja/iran-gay-men-hiv-gaps 2026-02-19T13:57:18.000Z daily 0.75 https://www.medxy.ai/news/estival-trial-vagus-nerve-stimulation 2026-02-19T13:56:55.000Z daily 0.75 https://www.medxy.ai/news/vi/estival-study-auditory-stimulation 2026-02-19T18:34:27.000Z daily 0.75 https://www.medxy.ai/news/ja/estival-trial-nerve-stimulation 2026-02-19T18:34:37.000Z daily 0.75 https://www.medxy.ai/news/zh/estival-trial-ear-stimulation 2026-02-19T18:34:43.000Z daily 0.75 https://www.medxy.ai/news/serplulimab-astrum-002 2026-02-19T14:04:02.000Z daily 0.75 https://www.medxy.ai/news/vi/serplulimab-lung-cancer-trial 2026-02-19T18:34:55.000Z daily 0.75 https://www.medxy.ai/news/ja/selpercatinib-chemotherapy-lung-cancer 2026-02-19T18:35:11.000Z daily 0.75 https://www.medxy.ai/news/zh/asitrm-002-nsclc-treatment 2026-02-19T18:35:15.000Z daily 0.75 https://www.medxy.ai/news/hidden-hyperinflammatory-crisis 2026-02-19T14:10:47.000Z daily 0.75 https://www.medxy.ai/news/vi/europe-inflammatory-storm 2026-02-19T18:35:30.000Z daily 0.75 https://www.medxy.ai/news/ja/hidden-inflammation-crisis 2026-02-19T18:35:45.000Z daily 0.75 https://www.medxy.ai/news/zh/europe-high-inflammation-crisis 2026-02-19T18:35:52.000Z daily 0.75 https://www.medxy.ai/news/subglottic-suction-failure 2026-02-19T14:17:11.000Z daily 0.75 https://www.medxy.ai/news/vi/polyurethane-valve-trial 2026-02-19T18:36:01.000Z daily 0.75 https://www.medxy.ai/news/ja/airway-suction-polyurethane-cuff 2026-02-19T18:36:08.000Z daily 0.75 https://www.medxy.ai/news/zh/vocal-cord-suction-failure 2026-02-19T18:36:15.000Z daily 0.75 https://www.medxy.ai/news/cervical-cancer-screening-hiv 2026-02-19T14:36:50.000Z daily 0.75 https://www.medxy.ai/news/vi/cervical-cancer-screening-hiv-2 2026-02-19T18:36:25.000Z daily 0.75 https://www.medxy.ai/news/ja/hiv-women-cervical-cancer-screening 2026-02-19T18:36:37.000Z daily 0.75 https://www.medxy.ai/news/zh/hiv-cervical-cancer-screening 2026-02-19T18:36:43.000Z daily 0.75 https://www.medxy.ai/news/tezepelumab-asthma-trial 2026-02-19T14:52:50.000Z daily 0.75 https://www.medxy.ai/news/vi/tezepelumab-asthma-treatment 2026-02-19T18:36:51.000Z daily 0.75 https://www.medxy.ai/news/ja/tezepelumab-asthma-study-2 2026-02-19T18:37:01.000Z daily 0.75 https://www.medxy.ai/news/zh/tezepelumab-asthma-study 2026-02-19T18:37:17.000Z daily 0.75 https://www.medxy.ai/news/planetary-health-diet-evidence 2026-02-19T14:58:08.000Z daily 0.75 https://www.medxy.ai/news/sonia-trial-cdk46-advancement 2026-02-19T18:40:08.000Z daily 0.75 https://www.medxy.ai/news/vi/strategic-timing-sonia-trial 2026-02-19T18:40:14.000Z daily 0.75 https://www.medxy.ai/news/ja/tactical-timing-sonia-trial-cdk46 2026-02-19T18:37:30.000Z daily 0.75 https://www.medxy.ai/news/zh/opportunity-strategy-sonia-trial-cdk46-invasive-breast-cancer 2026-02-19T18:37:35.000Z daily 0.75 https://www.medxy.ai/news/stereotactic-radiation-quality-of-life 2026-02-19T17:38:39.000Z daily 0.75 https://www.medxy.ai/news/vi/quantitative-analysis-quality-of-life 2026-02-19T18:37:49.000Z daily 0.75 https://www.medxy.ai/news/ja/stereotactic-radiation-quality-of-life-2 2026-02-19T18:37:58.000Z daily 0.75 https://www.medxy.ai/news/zh/stereotactic-radiation-superior 2026-02-19T18:38:11.000Z daily 0.75 https://www.medxy.ai/news/rapid-fluid-resolution-faricimab 2026-02-19T17:44:30.000Z daily 0.75 https://www.medxy.ai/news/vi/fast-liquid-resolution-faricimab 2026-02-19T18:38:17.000Z daily 0.75 https://www.medxy.ai/news/ja/early-fluid-resolution-namd-prediction 2026-02-19T18:38:21.000Z daily 0.75 https://www.medxy.ai/news/zh/rapid-prediction-namd-durability 2026-02-19T18:38:27.000Z daily 0.75 https://www.medxy.ai/news/pth-guided-calcium-supplementation 2026-02-19T17:57:43.000Z daily 0.75 https://www.medxy.ai/news/vi/calcium-supplementation-thyroid-surgery 2026-02-19T18:38:38.000Z daily 0.75 https://www.medxy.ai/news/ja/post-thyroidectomy-calcium-supplementation 2026-02-19T18:38:48.000Z daily 0.75 https://www.medxy.ai/news/zh/total-thyroidectomy-pth-calcium 2026-02-19T18:38:55.000Z daily 0.75 https://www.medxy.ai/news/pembrolizumab-hnc-market 2026-02-19T18:25:57.000Z daily 0.75 https://www.medxy.ai/news/vi/pembrolizumab-hnc-market-dominance 2026-02-19T18:39:17.000Z daily 0.75 https://www.medxy.ai/news/ja/pembrolizumab-head-neck-cancer 2026-02-19T18:39:25.000Z daily 0.75 https://www.medxy.ai/news/zh/pembrolizumab-head-and-neck-cancer 2026-02-19T18:39:32.000Z daily 0.75 https://www.medxy.ai/news/spirituality-protective-factor 2026-02-19T18:33:40.000Z daily 0.75 https://www.medxy.ai/news/vi/spirituality-as-protective-factor 2026-02-19T18:39:40.000Z daily 0.75 https://www.medxy.ai/news/ja/mental-factors-substance-use-disorder 2026-02-19T18:39:48.000Z daily 0.75 https://www.medxy.ai/news/zh/mental-health-and-substance-use 2026-02-19T18:39:58.000Z daily 0.75 https://www.medxy.ai/news/long-term-parity-adhesiolysis-results 2026-02-19T18:41:18.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-equity-in-surgery 2026-02-19T19:53:28.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-parity-lasso-trial 2026-02-19T19:53:35.000Z daily 0.75 https://www.medxy.ai/news/zh/laparoscopic-adhesiolysis-long-term-results 2026-02-19T19:53:45.000Z daily 0.75 https://www.medxy.ai/news/gnrh-agonists-coronary-plaque 2026-02-19T19:26:58.000Z daily 0.75 https://www.medxy.ai/news/vi/gnrh-agonists-coronary-artery-disease 2026-02-19T19:53:56.000Z daily 0.75 https://www.medxy.ai/news/ja/gnrh-agonist-vs-antagonist 2026-02-19T19:54:06.000Z daily 0.75 https://www.medxy.ai/news/zh/gnrh-agonists-vs-antagonists 2026-02-19T19:54:14.000Z daily 0.75 https://www.medxy.ai/news/bimekizumab-psoriasis-trial 2026-02-19T19:51:42.000Z daily 0.75 https://www.medxy.ai/news/vi/bimekizumab-psoriasis-trials 2026-02-19T19:54:22.000Z daily 0.75 https://www.medxy.ai/news/ja/bimekizumab-skin-clearance-quality-of-life 2026-02-20T08:14:02.000Z daily 0.75 https://www.medxy.ai/news/zh/bimekizumab-psoriasis-study 2026-02-20T08:14:07.000Z daily 0.75 https://www.medxy.ai/news/mindfulness-vs-standard-care 2026-02-19T20:00:56.000Z daily 0.75 https://www.medxy.ai/news/vi/myriad-trial-teen-mental-health 2026-02-20T08:14:16.000Z daily 0.75 https://www.medxy.ai/news/ja/mindfulness-and-mental-health 2026-02-20T08:14:24.000Z daily 0.75 https://www.medxy.ai/news/zh/universal-school-mental-health-training 2026-02-20T08:14:30.000Z daily 0.75 https://www.medxy.ai/news/ctdna-detects-nodal-metastasis 2026-02-20T09:26:15.000Z daily 0.75 https://www.medxy.ai/news/vi/ctdna-esophageal-cancer 2026-02-20T09:26:45.000Z daily 0.75 https://www.medxy.ai/news/ja/ctdna-detection-esophageal-cancer 2026-02-20T09:27:07.000Z daily 0.75 https://www.medxy.ai/news/zh/ctdna-early-esophageal-cancer 2026-02-20T09:27:21.000Z daily 0.75 https://www.medxy.ai/news/high-volume-ems-survival 2026-02-20T09:21:26.000Z daily 0.75 https://www.medxy.ai/news/vi/ems-doctors-saving-lives 2026-02-20T09:27:30.000Z daily 0.75 https://www.medxy.ai/news/ja/emergency-medicine-survival-rates 2026-02-20T09:27:42.000Z daily 0.75 https://www.medxy.ai/news/zh/high-capacity-rescue-heroes 2026-02-20T09:27:48.000Z daily 0.75 https://www.medxy.ai/news/pregnancy-and-longevity 2026-02-22T22:43:13.000Z daily 0.75 https://www.medxy.ai/news/vi/pregnancy-and-heart-health 2026-02-22T22:37:02.000Z daily 0.75 https://www.medxy.ai/news/ja/pregnancy-and-longevity-3 2026-02-22T22:36:53.000Z daily 0.75 https://www.medxy.ai/news/zh/pregnancy-and-longevity-2 2026-02-22T22:36:39.000Z daily 0.75 https://www.medxy.ai/news/rapid-acting-neuroplastogen-ptsd-results 2026-02-20T10:04:09.000Z daily 0.75 https://www.medxy.ai/news/vi/neuroplastogen-ptsd-results 2026-02-22T22:36:19.000Z daily 0.75 https://www.medxy.ai/news/ja/tsnd-201-ptsd-treatment 2026-02-22T22:36:11.000Z daily 0.75 https://www.medxy.ai/news/zh/rapid-tsnd-201-ptsd-results 2026-02-22T22:36:05.000Z daily 0.75 https://www.medxy.ai/news/dupilumab-for-chronic-urticaria 2026-02-20T10:09:52.000Z daily 0.75 https://www.medxy.ai/news/vi/dupilumab-for-chronic-urticaria-2 2026-02-22T22:35:56.000Z daily 0.75 https://www.medxy.ai/news/ja/duplizumab-chronic-urticaria 2026-02-22T22:35:49.000Z daily 0.75 https://www.medxy.ai/news/zh/duplizumab-chronic-urticaria-2 2026-02-22T22:35:41.000Z daily 0.75 https://www.medxy.ai/news/long-term-ublituximab-in-ms 2026-02-20T10:17:00.000Z daily 0.75 https://www.medxy.ai/news/vi/ublituximab-long-term-results 2026-02-22T22:35:26.000Z daily 0.75 https://www.medxy.ai/news/ja/ms-ublituximab-therapy-results 2026-02-22T22:35:13.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-ublituximab-ms-results 2026-02-22T22:34:54.000Z daily 0.75 https://www.medxy.ai/news/redefining-cardiac-arrest-care 2026-02-20T10:32:51.000Z daily 0.75 https://www.medxy.ai/news/vi/redefining-post-cardiac-arrest-care 2026-02-22T22:31:55.000Z daily 0.75 https://www.medxy.ai/news/ja/redesigning-post-cardiac-arrest-treatment 2026-02-22T22:31:49.000Z daily 0.75 https://www.medxy.ai/news/zh/redefining-cardiac-arrest-care-2 2026-02-22T22:31:38.000Z daily 0.75 https://www.medxy.ai/news/produce-prescriptions-diabetes-outcomes 2026-02-20T11:25:12.000Z daily 0.75 https://www.medxy.ai/news/vi/diabetes-trial-lessons 2026-02-22T21:47:22.000Z daily 0.75 https://www.medxy.ai/news/ja/vegetable-prescription-diabetes-results 2026-02-22T21:47:12.000Z daily 0.75 https://www.medxy.ai/news/zh/food-prescription-lessons 2026-02-22T21:47:03.000Z daily 0.75 https://www.medxy.ai/news/acetaminophen-preterm-infants 2026-02-20T11:31:23.000Z daily 0.75 https://www.medxy.ai/news/vi/paracetamol-non-month-survival 2026-02-22T21:46:48.000Z daily 0.75 https://www.medxy.ai/news/ja/preventive-acetaminophen-preterm-survival 2026-02-22T21:46:39.000Z daily 0.75 https://www.medxy.ai/news/zh/preventive-acetaminophen-fails-survival 2026-02-22T21:46:30.000Z daily 0.75 https://www.medxy.ai/news/early-ibuprofen-fails-outcomes 2026-02-20T12:14:55.000Z daily 0.75 https://www.medxy.ai/news/vi/early-ibuprofen-ductus-arteriosus 2026-02-22T21:46:12.000Z daily 0.75 https://www.medxy.ai/news/zh/early-ibuprofen-treatment-outcomes 2026-02-22T21:45:59.000Z daily 0.75 https://www.medxy.ai/news/sex-specific-tau-dynamics 2026-02-20T12:31:26.000Z daily 0.75 https://www.medxy.ai/news/vi/p-tau217-and-women 2026-02-22T21:45:37.000Z daily 0.75 https://www.medxy.ai/news/ja/sex-difference-p-tau-dynamics 2026-02-22T21:45:29.000Z daily 0.75 https://www.medxy.ai/news/zh/gender-specific-p-tau217-dynamics 2026-02-22T21:45:18.000Z daily 0.75 https://www.medxy.ai/news/salvage-focal-therapy-vs-radical-prostatectomy 2026-02-20T14:54:43.000Z daily 0.75 https://www.medxy.ai/news/vi/treatment-vs-prostatectomy 2026-02-22T21:45:05.000Z daily 0.75 https://www.medxy.ai/news/ja/recurrent-local-therapy-prostatectomy 2026-02-22T21:44:58.000Z daily 0.75 https://www.medxy.ai/news/zh/salvage-vs-radical-prostatectomy 2026-02-22T21:44:45.000Z daily 0.75 https://www.medxy.ai/news/precision-oncology-ai-egfr-prediction 2026-02-22T21:44:29.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-cancer-ai-prediction 2026-02-22T21:39:43.000Z daily 0.75 https://www.medxy.ai/news/ja/precision-oncology-ai 2026-02-22T21:39:32.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-oncology-ai-variant-impact 2026-02-22T21:39:22.000Z daily 0.75 https://www.medxy.ai/news/optimizing-ajcc-version9-salivary-cancer 2026-02-20T18:07:14.000Z daily 0.75 https://www.medxy.ai/news/vi/ajcc-version-9-salivary-gland-cancer 2026-02-22T21:39:05.000Z daily 0.75 https://www.medxy.ai/news/ja/optimal-outcomes-salivary-gland-cancer 2026-02-22T21:38:58.000Z daily 0.75 https://www.medxy.ai/news/zh/optimized-outlook-salivary-gland-cancer 2026-02-22T21:38:52.000Z daily 0.75 https://www.medxy.ai/news/prasugrel-gold-standard 2026-02-20T19:51:57.000Z daily 0.75 https://www.medxy.ai/news/vi/prasugrel-new-gold-standard 2026-02-22T21:38:35.000Z daily 0.75 https://www.medxy.ai/news/ja/prasugrel-gold-standard-2 2026-02-22T21:38:31.000Z daily 0.75 https://www.medxy.ai/news/zh/plagrey-new-standard 2026-02-22T21:38:26.000Z daily 0.75 https://www.medxy.ai/news/handheld-assist-device-success 2026-02-21T17:05:31.000Z daily 0.75 https://www.medxy.ai/news/vi/new-handheld-device-success 2026-02-22T21:37:27.000Z daily 0.75 https://www.medxy.ai/news/zh/valsava-success-rate 2026-02-22T21:37:17.000Z daily 0.75 https://www.medxy.ai/news/rest-activity-rhythms-biomarkers 2026-02-21T17:32:20.000Z daily 0.75 https://www.medxy.ai/news/vi/activity-rest-patterns 2026-02-22T21:37:01.000Z daily 0.75 https://www.medxy.ai/news/zh/activity-rhythm-biomarker 2026-02-22T21:36:48.000Z daily 0.75 https://www.medxy.ai/news/lifi-post-transplant-mortality 2026-02-21T23:57:50.000Z daily 0.75 https://www.medxy.ai/news/vi/lifi-predicts-mortality 2026-02-22T21:36:39.000Z daily 0.75 https://www.medxy.ai/news/ja/meld-beyond-lifi-predicts-mortality 2026-02-22T21:36:33.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-meld-lifi 2026-02-22T21:36:19.000Z daily 0.75 https://www.medxy.ai/news/bridging-the-gap-atopic-dermatitis 2026-02-22T07:45:46.000Z daily 0.75 https://www.medxy.ai/news/vi/decision-support-tool 2026-02-22T21:36:09.000Z daily 0.75 https://www.medxy.ai/news/ja/gap-filling-atopic-dermatitis-tool 2026-02-22T21:36:00.000Z daily 0.75 https://www.medxy.ai/news/zh/bridging-the-gap-atopic-eczema-tool 2026-02-22T21:35:52.000Z daily 0.75 https://www.medxy.ai/news/buprenorphine-options-emergency-care 2026-02-22T10:23:03.000Z daily 0.75 https://www.medxy.ai/news/vi/buprenorphine-comparison 2026-02-22T21:35:39.000Z daily 0.75 https://www.medxy.ai/news/ja/buprenorphine-injection-vs-sublingual 2026-02-22T21:35:30.000Z daily 0.75 https://www.medxy.ai/news/zh/buprenorphine-injection-sublingual-care 2026-02-22T21:35:22.000Z daily 0.75 https://www.medxy.ai/news/quantitative-plaque-volume 2026-02-22T10:30:19.000Z daily 0.75 https://www.medxy.ai/news/vi/after-stenosis-vascular-volume 2026-02-22T21:35:05.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-narrowing-cardiac-risk 2026-02-22T21:34:55.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-narrowness-quantitative-plaque-volume 2026-02-22T21:34:49.000Z daily 0.75 https://www.medxy.ai/news/human-ai-collaboration-ophthalmology 2026-02-22T13:03:22.000Z daily 0.75 https://www.medxy.ai/news/vi/human-ai-collaboration-ophthalmology-3 2026-02-22T21:34:39.000Z daily 0.75 https://www.medxy.ai/news/ja/human-ai-collaboration-ophthalmology-2 2026-02-22T21:34:32.000Z daily 0.75 https://www.medxy.ai/news/zh/human-machine-collaboration-ophthalmology 2026-02-22T21:34:25.000Z daily 0.75 https://www.medxy.ai/news/delpacibart-etedesiran-myotonic-dystrophy 2026-02-22T17:03:01.000Z daily 0.75 https://www.medxy.ai/news/ja/delpasibart-miotonin-dystrophy 2026-02-22T21:34:12.000Z daily 0.75 https://www.medxy.ai/news/zh/delpacibart-etedesiran-potential 2026-02-22T21:34:05.000Z daily 0.75 https://www.medxy.ai/news/cystine-barrier-gene-therapy 2026-02-22T17:06:48.000Z daily 0.75 https://www.medxy.ai/news/vi/cystine-barrier-breakthrough 2026-02-22T21:33:34.000Z daily 0.75 https://www.medxy.ai/news/ja/cystinosis-gene-therapy-safety 2026-02-22T21:33:46.000Z daily 0.75 https://www.medxy.ai/news/zh/cystine-therapy-safety 2026-02-22T21:33:54.000Z daily 0.75 https://www.medxy.ai/news/tavr-vs-surgery-results 2026-02-22T17:48:27.000Z daily 0.75 https://www.medxy.ai/news/vi/tavr-vs-surgery-low-risk 2026-02-22T21:33:00.000Z daily 0.75 https://www.medxy.ai/news/ja/tavr-vs-surgery-partner3-results 2026-02-22T21:32:53.000Z daily 0.75 https://www.medxy.ai/news/zh/tavr-vs-surgery-long-term-results 2026-02-22T21:32:30.000Z daily 0.75 https://www.medxy.ai/news/long-acting-injectable-art 2026-02-22T21:31:29.000Z daily 0.75 https://www.medxy.ai/news/vi/arv-injection-study 2026-02-22T22:38:15.000Z daily 0.75 https://www.medxy.ai/news/ja/hiv-injection-art-study 2026-02-22T22:38:21.000Z daily 0.75 https://www.medxy.ai/news/zh/long-acting-hiv-treatment-2 2026-02-22T22:38:27.000Z daily 0.75 https://www.medxy.ai/news/perioperative-enfortumab-pembrolizumab-bladder-cancer 2026-02-22T21:38:28.000Z daily 0.75 https://www.medxy.ai/news/vi/enfortumab-pembrolizumab-bladder-cancer-2 2026-02-22T22:38:39.000Z daily 0.75 https://www.medxy.ai/news/ja/enfortumab-pembrolizumab-bladder-cancer 2026-02-22T22:38:47.000Z daily 0.75 https://www.medxy.ai/news/zh/intraoperative-immunotherapy-bladder-cancer 2026-02-22T22:38:54.000Z daily 0.75 https://www.medxy.ai/news/molecular-mimicry-vitt 2026-02-22T22:32:25.000Z daily 0.75 https://www.medxy.ai/news/vi/somatic-hypermutation-adenovirus 2026-02-22T22:39:07.000Z daily 0.75 https://www.medxy.ai/news/ja/molecular-mimicry-vitt-mechanism 2026-02-22T22:39:13.000Z daily 0.75 https://www.medxy.ai/news/zh/molecular-simulation-vitt 2026-02-22T22:41:43.000Z daily 0.75 https://www.medxy.ai/news/sibeprenlimab-proteinuria-reduction 2026-02-22T22:43:59.000Z daily 0.75 https://www.medxy.ai/news/vi/sibeprenlimab-51-protein-nieu 2026-02-23T09:14:12.000Z daily 0.75 https://www.medxy.ai/news/ja/sibeprenlimab-iga-renal-results 2026-02-23T09:14:22.000Z daily 0.75 https://www.medxy.ai/news/zh/sibeprenlimab-iga-kidney-disease 2026-02-23T09:14:34.000Z daily 0.75 https://www.medxy.ai/news/wolbachia-mosquitoes-dengue-risk 2026-02-22T22:58:56.000Z daily 0.75 https://www.medxy.ai/news/vi/aedes-aegypti-wolbachia-dengue 2026-02-23T09:14:46.000Z daily 0.75 https://www.medxy.ai/news/ja/wolbachia-mosquito-release 2026-02-23T09:15:07.000Z daily 0.75 https://www.medxy.ai/news/zh/strategic-release-mosquitoes 2026-02-23T09:15:16.000Z daily 0.75 https://www.medxy.ai/news/vi/vitamin-d-ivf-pcos 2026-02-23T08:55:23.000Z daily 0.75 https://www.medxy.ai/news/vi/vitamin-d-ivf-pcos-2 2026-02-23T09:15:24.000Z daily 0.75 https://www.medxy.ai/news/ja/vitamin-d-pcos-study-2 2026-02-23T09:15:28.000Z daily 0.75 https://www.medxy.ai/news/zh/vitamin-d-pcos-study 2026-02-23T09:15:34.000Z daily 0.75 https://www.medxy.ai/news/ultrasound-viscoelastic-imaging 2026-02-23T09:04:25.000Z daily 0.75 https://www.medxy.ai/news/vi/ultrasound-diagnosis-nephritis 2026-02-23T09:15:45.000Z daily 0.75 https://www.medxy.ai/news/ja/ultrasound-vasculitis-diagnosis 2026-02-23T09:15:51.000Z daily 0.75 https://www.medxy.ai/news/zh/ultrasound-elastography-children-purpura 2026-02-23T09:15:59.000Z daily 0.75 https://www.medxy.ai/news/pharmacist-led-warfarin-management 2026-02-23T09:09:53.000Z daily 0.75 https://www.medxy.ai/news/vi/warfarin-management-heart-valve-patients 2026-02-23T09:16:19.000Z daily 0.75 https://www.medxy.ai/news/ja/pharmacist-led-testing 2026-02-25T23:35:53.000Z daily 0.75 https://www.medxy.ai/news/zh/pharmacist-led-patient-self-monitoring 2026-02-25T23:35:57.000Z daily 0.75 https://www.medxy.ai/news/knee-bracing-results 2026-02-23T12:59:53.000Z daily 0.75 https://www.medxy.ai/news/vi/knee-brace-use-arthritis-results 2026-02-25T23:35:24.000Z daily 0.75 https://www.medxy.ai/news/ja/knee-brace-treatment-results 2026-02-25T23:35:34.000Z daily 0.75 https://www.medxy.ai/news/zh/knee-brace-oai-results 2026-02-25T23:35:41.000Z daily 0.75 https://www.medxy.ai/news/telesurgery-non-inferiority 2026-02-25T23:35:11.000Z daily 0.75 https://www.medxy.ai/news/vi/remote-surgery-vs-robotics 2026-02-25T23:34:58.000Z daily 0.75 https://www.medxy.ai/news/ja/remote-surgery-breaks-barriers 2026-02-25T23:34:46.000Z daily 0.75 https://www.medxy.ai/news/zh/remote-surgery-equality 2026-02-25T23:34:38.000Z daily 0.75 https://www.medxy.ai/news/benfotiamine-diabetic-polyneuropathy 2026-02-23T13:33:01.000Z daily 0.75 https://www.medxy.ai/news/vi/benfotiamine-diabetes-neuropathy 2026-02-25T23:34:13.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-benfotiamine-ineffective 2026-02-25T23:34:20.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-treatment-diabetic-neuropathy 2026-02-25T23:34:29.000Z daily 0.75 https://www.medxy.ai/news/synergistic-neuromodulation 2026-02-23T13:51:27.000Z daily 0.75 https://www.medxy.ai/news/vi/neurostimulation-combination-depression 2026-02-25T23:33:36.000Z daily 0.75 https://www.medxy.ai/news/ja/neuro-modulation-benefits 2026-02-25T23:33:42.000Z daily 0.75 https://www.medxy.ai/news/zh/cooperative-neuro-modulation 2026-02-25T23:33:47.000Z daily 0.75 https://www.medxy.ai/news/kangaroo-care-pain-inflammation 2026-02-25T23:32:55.000Z daily 0.75 https://www.medxy.ai/news/vi/kangaroo-care-pain-relief 2026-02-25T23:33:08.000Z daily 0.75 https://www.medxy.ai/news/ja/kangaroo-care-premature-retinopathy-symptoms 2026-02-25T23:33:16.000Z daily 0.75 https://www.medxy.ai/news/zh/kangaroo-care-prematurity-visit 2026-02-25T23:33:28.000Z daily 0.75 https://www.medxy.ai/news/predicting-tumbles-copd 2026-02-23T15:23:31.000Z daily 0.75 https://www.medxy.ai/news/vi/fall-prediction-copd 2026-02-25T23:32:26.000Z daily 0.75 https://www.medxy.ai/news/ja/falls-prediction-copd 2026-02-25T23:32:37.000Z daily 0.75 https://www.medxy.ai/news/zh/predicted-falls-copd-risk 2026-02-25T23:32:42.000Z daily 0.75 https://www.medxy.ai/news/china-workforce-cancer-risk 2026-02-23T15:29:40.000Z daily 0.75 https://www.medxy.ai/news/vi/chinese-workers-cancer-risk 2026-02-25T23:30:16.000Z daily 0.75 https://www.medxy.ai/news/ja/china-worker-cancer-risk 2026-02-25T23:32:07.000Z daily 0.75 https://www.medxy.ai/news/zh/china-labor-cancer-risk 2026-02-25T23:31:55.000Z daily 0.75 https://www.medxy.ai/news/aav9-gene-therapy-gm1-gangliosidosis 2026-02-23T15:51:08.000Z daily 0.75 https://www.medxy.ai/news/vi/aav9-gene-therapy-gm1-gangliosidosis-2 2026-02-25T23:30:02.000Z daily 0.75 https://www.medxy.ai/news/ja/aav9-gene-therapy-gm1 2026-02-25T23:29:51.000Z daily 0.75 https://www.medxy.ai/news/zh/aav9-gene-therapy-gm1-2 2026-02-25T23:29:41.000Z daily 0.75 https://www.medxy.ai/news/letrozole-abemaciclib-metformin-triple-therapy 2026-02-23T16:05:33.000Z daily 0.75 https://www.medxy.ai/news/vi/letrozole-abemaciclib-metformin 2026-02-25T23:29:31.000Z daily 0.75 https://www.medxy.ai/news/ja/retrozoal-abemaciclib-metformin-efficacy 2026-02-25T23:29:24.000Z daily 0.75 https://www.medxy.ai/news/zh/letrozole-abemaciclib-metformin-combo 2026-02-25T23:29:14.000Z daily 0.75 https://www.medxy.ai/news/metformin-walking-performance-failure 2026-02-23T16:16:04.000Z daily 0.75 https://www.medxy.ai/news/vi/metformin-legs-study 2026-02-25T23:29:02.000Z daily 0.75 https://www.medxy.ai/news/ja/metformin-does-not-improve-gait-function 2026-02-25T23:28:51.000Z daily 0.75 https://www.medxy.ai/news/zh/metformin-and-peripheral-artery-disease 2026-02-25T23:28:44.000Z daily 0.75 https://www.medxy.ai/news/albumin-replacement-septic-shock 2026-02-23T16:21:41.000Z daily 0.75 https://www.medxy.ai/news/vi/albumin-replacement-sepsis 2026-02-25T23:28:37.000Z daily 0.75 https://www.medxy.ai/news/ja/albumin-replacement-therapy 2026-02-25T23:28:29.000Z daily 0.75 https://www.medxy.ai/news/zh/albumin-use-in-shock 2026-02-25T23:28:23.000Z daily 0.75 https://www.medxy.ai/news/precision-medicine-opioid-trial 2026-02-23T17:21:42.000Z daily 0.75 https://www.medxy.ai/news/vi/opioid-guideline-trial 2026-02-25T23:27:49.000Z daily 0.75 https://www.medxy.ai/news/ja/precision-medicine-postop-pain 2026-02-25T23:28:02.000Z daily 0.75 https://www.medxy.ai/news/zh/precision-medicine-pain-insight 2026-02-25T23:28:10.000Z daily 0.75 https://www.medxy.ai/news/proactive-pharmacist-outreach 2026-02-23T19:04:22.000Z daily 0.75 https://www.medxy.ai/news/vi/active-pharmacist-intervention 2026-02-25T23:27:14.000Z daily 0.75 https://www.medxy.ai/news/ja/proactive-pharmacist-outreach-2 2026-02-25T23:27:07.000Z daily 0.75 https://www.medxy.ai/news/zh/active-pharmacist-intervention-2dm 2026-02-25T23:26:59.000Z daily 0.75 https://www.medxy.ai/news/high-intensity-circuit-training-sleep-health 2026-02-23T20:53:00.000Z daily 0.75 https://www.medxy.ai/news/synergy-high-intensity-training-sleep 2026-02-23T20:55:50.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-training-high-intensity-sleep 2026-02-25T23:26:48.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-solo-workouts 2026-02-25T23:26:29.000Z daily 0.75 https://www.medxy.ai/news/zh/high-intensity-training-sleep-health 2026-02-25T23:26:38.000Z daily 0.75 https://www.medxy.ai/news/embrace-trial-insights 2026-02-23T21:13:00.000Z daily 0.75 https://www.medxy.ai/news/vi/enhanced-care-postpartum-depression 2026-02-25T23:26:05.000Z daily 0.75 https://www.medxy.ai/news/ja/enhanced-care-postpartum-depression-2 2026-02-25T23:25:55.000Z daily 0.75 https://www.medxy.ai/news/zh/strengthening-care-reduces-postpartum-depression 2026-02-25T23:25:41.000Z daily 0.75 https://www.medxy.ai/news/intensive-blood-pressure-targets 2026-02-24T09:12:30.000Z daily 0.75 https://www.medxy.ai/news/zh/under-130-80-bp-benefits 2026-02-25T23:25:27.000Z daily 0.75 https://www.medxy.ai/news/ja/blood-pressure-goal-benefits 2026-02-25T23:25:18.000Z daily 0.75 https://www.medxy.ai/news/kids-voice-patient-outcomes 2026-02-25T23:25:04.000Z daily 0.75 https://www.medxy.ai/news/healing-heart-tradition 2026-02-24T10:55:10.000Z daily 0.75 https://www.medxy.ai/news/survivorship-care-plans-cardiovascular-risk 2026-02-24T11:01:34.000Z daily 0.75 https://www.medxy.ai/news/vi/cancer-survivor-care-plans 2026-02-25T23:24:44.000Z daily 0.75 https://www.medxy.ai/news/ja/cancer-survivor-care-plan 2026-02-25T21:44:57.000Z daily 0.75 https://www.medxy.ai/news/zh/survivor-care-cardiovascular-risk 2026-02-25T21:44:46.000Z daily 0.75 https://www.medxy.ai/news/mobile-app-acupressure 2026-02-24T11:14:57.000Z daily 0.75 https://www.medxy.ai/news/zh/self-press-app-for-fatigue 2026-02-25T21:44:24.000Z daily 0.75 https://www.medxy.ai/news/ja/mobile-app-acupressure-2 2026-02-25T21:44:09.000Z daily 0.75 https://www.medxy.ai/news/preventing-epilepsy-stroke 2026-02-24T11:28:24.000Z daily 0.75 https://www.medxy.ai/news/vi/seizure-prevention-stroke 2026-02-25T21:43:51.000Z daily 0.75 https://www.medxy.ai/news/ja/post-stroke-epilepsy-prevention 2026-02-25T21:43:46.000Z daily 0.75 https://www.medxy.ai/news/zh/prevention-of-stroke-seizures 2026-02-25T21:43:40.000Z daily 0.75 https://www.medxy.ai/news/ciffreo-trial-results 2026-02-24T11:35:17.000Z daily 0.75 https://www.medxy.ai/news/vi/ciffreo-results-duchenne 2026-02-25T21:43:27.000Z daily 0.75 https://www.medxy.ai/news/ja/ciffreo-results-dmd 2026-02-25T21:43:17.000Z daily 0.75 https://www.medxy.ai/news/zh/ciffreo-results-fordadistrogene 2026-02-25T21:43:09.000Z daily 0.75 https://www.medxy.ai/news/digital-imagery-trauma-intervention 2026-02-25T21:42:58.000Z daily 0.75 https://www.medxy.ai/news/vi/digital-image-research 2026-02-25T21:42:41.000Z daily 0.75 https://www.medxy.ai/news/ja/digital-image-intervention 2026-02-25T21:42:23.000Z daily 0.75 https://www.medxy.ai/news/zh/digital-imaging-intervention 2026-02-25T21:42:05.000Z daily 0.75 https://www.medxy.ai/news/tobacco-cessation-hiv-care 2026-02-25T21:41:42.000Z daily 0.75 https://www.medxy.ai/news/vi/hiv-smoking-cessation 2026-02-25T21:41:22.000Z daily 0.75 https://www.medxy.ai/news/ja/hiv-care-smoking-cessation 2026-02-25T21:41:10.000Z daily 0.75 https://www.medxy.ai/news/zh/hiv-quitline-intervention 2026-02-25T21:41:00.000Z daily 0.75 https://www.medxy.ai/news/brief-psychological-intervention-no-benefit 2026-03-02T10:12:13.000Z daily 0.75 https://www.medxy.ai/news/vi/short-therapy-personality-disorder 2026-02-25T21:40:49.000Z daily 0.75 https://www.medxy.ai/news/ja/no-effect-short-psych-intervention 2026-02-24T16:33:23.000Z daily 0.75 https://www.medxy.ai/news/zh/short-psych-intervention-for-personality-disorders 2026-02-25T21:40:40.000Z daily 0.75 https://www.medxy.ai/news/romosozumab-denosumab-osteoporosis 2026-02-24T16:35:12.000Z daily 0.75 https://www.medxy.ai/news/vi/romosozumab-vs-denosumab 2026-02-25T21:40:34.000Z daily 0.75 https://www.medxy.ai/news/paxg-vs-mfolfirinox-3 2026-03-02T10:12:08.000Z daily 0.75 https://www.medxy.ai/news/vi/cassandra-trial-paxg-mfolfirinox 2026-02-25T21:40:17.000Z daily 0.75 https://www.medxy.ai/news/ja/cassandra-insights-pancancer-care 2026-02-25T21:40:11.000Z daily 0.75 https://www.medxy.ai/news/zh/cassandra-trial-insights 2026-02-25T21:40:04.000Z daily 0.75 https://www.medxy.ai/news/twice-yearly-inclisiran-ldl-c-adolescents 2026-02-24T17:49:44.000Z daily 0.75 https://www.medxy.ai/news/vi/inclisiran-ldl-c-teenagers 2026-02-25T21:39:56.000Z daily 0.75 https://www.medxy.ai/news/ja/orion-16-lowering-ldl-c 2026-02-25T21:39:48.000Z daily 0.75 https://www.medxy.ai/news/zh/inclisiran-lowers-ldl-c 2026-02-25T21:39:40.000Z daily 0.75 https://www.medxy.ai/news/cyclic-enteral-nutrition 2026-03-02T10:12:05.000Z daily 0.75 https://www.medxy.ai/news/vi/digestive-nutrition-model 2026-02-25T21:39:25.000Z daily 0.75 https://www.medxy.ai/news/zh/periodic-enteral-nutrition 2026-02-25T21:39:04.000Z daily 0.75 https://www.medxy.ai/news/potent-antiviral-alg-000184 2026-03-02T10:12:02.000Z daily 0.75 https://www.medxy.ai/news/vi/strong-antiviral-activity-alg-000184 2026-02-25T21:29:10.000Z daily 0.75 https://www.medxy.ai/news/ja/strong-antiviral-effect-of-alg-000184 2026-02-25T21:29:02.000Z daily 0.75 https://www.medxy.ai/news/zh/e-class-assembly-agent-alg-000184-antiviral-activity 2026-02-25T21:28:52.000Z daily 0.75 https://www.medxy.ai/news/potent-viral-suppression-alg-000184 2026-03-02T10:11:55.000Z daily 0.75 https://www.medxy.ai/news/vi/viral-pressure-safety-alg-000184 2026-02-25T21:28:39.000Z daily 0.75 https://www.medxy.ai/news/zh/strong-viral-suppression-hbv 2026-02-25T21:28:19.000Z daily 0.75 https://www.medxy.ai/news/adjunctive-ultrasonography-breast-cancer 2026-03-02T10:11:51.000Z daily 0.75 https://www.medxy.ai/news/long-term-ultrasonography-breast-cancer 2026-02-25T11:02:19.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-effects-ultrasound-breast-cancer 2026-02-25T21:27:50.000Z daily 0.75 https://www.medxy.ai/news/ja/ultrasound-effects-breast-cancer 2026-02-25T21:27:40.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-effects-of-ultrasound 2026-02-25T21:27:22.000Z daily 0.75 https://www.medxy.ai/news/minocycline-stroke-recovery 2026-03-02T10:11:48.000Z daily 0.75 https://www.medxy.ai/news/vi/minocycline-stroke-recovery-4 2026-02-25T21:27:08.000Z daily 0.75 https://www.medxy.ai/news/ja/minocycline-stroke-recovery-3 2026-02-25T21:26:56.000Z daily 0.75 https://www.medxy.ai/news/zh/minocycline-stroke-recovery-2 2026-02-25T21:26:41.000Z daily 0.75 https://www.medxy.ai/news/ai-stethoscopes-implementation 2026-03-02T10:11:44.000Z daily 0.75 https://www.medxy.ai/news/vi/nuclear-ai-doctor-care 2026-02-25T21:25:59.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-ai-stethoscope 2026-02-25T13:52:35.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-stethoscope-in-healthcare 2026-02-25T13:52:27.000Z daily 0.75 https://www.medxy.ai/news/ensitrelvir-antiviral-efficacy 2026-03-02T10:11:39.000Z daily 0.75 https://www.medxy.ai/news/vi/ensitrelvir-vs-nirmatrelvir-covid-19 2026-02-25T13:52:18.000Z daily 0.75 https://www.medxy.ai/news/ja/ensitrelvir-covid-effect 2026-02-25T21:25:48.000Z daily 0.75 https://www.medxy.ai/news/zh/enzalutamide-covid-antiviral-efficacy 2026-02-25T21:25:42.000Z daily 0.75 https://www.medxy.ai/news/ai-mammography-masai-trial 2026-03-02T10:11:32.000Z daily 0.75 https://www.medxy.ai/news/vi/ai-enhanced-breast-imaging 2026-02-25T21:25:25.000Z daily 0.75 https://www.medxy.ai/news/ja/ai-mammography-masai-insights 2026-02-25T21:25:14.000Z daily 0.75 https://www.medxy.ai/news/zh/ai-breast-xray-masai-insight 2026-02-25T21:25:08.000Z daily 0.75 https://www.medxy.ai/news/fractional-yellow-fever-vaccination-failure 2026-03-02T10:11:27.000Z daily 0.75 https://www.medxy.ai/news/vi/vaccine-dose-standards-infants 2026-02-25T21:24:11.000Z daily 0.75 https://www.medxy.ai/news/ja/yellow-fever-vaccine-failure 2026-02-25T21:23:28.000Z daily 0.75 https://www.medxy.ai/news/savolitinib-osimertinib-nsclc-4 2026-03-02T10:11:24.000Z daily 0.75 https://www.medxy.ai/news/zh/yellow-fever-vaccine-dosing-issues 2026-02-25T21:23:11.000Z daily 0.75 https://www.medxy.ai/news/vi/savolitinib-osimertinib-nsclc-3 2026-02-25T21:22:53.000Z daily 0.75 https://www.medxy.ai/news/ja/savoritinib-osimertinib-nsclc 2026-02-25T21:22:47.000Z daily 0.75 https://www.medxy.ai/news/zh/savolitinib-osimertinib-nsclc-2 2026-02-25T21:22:41.000Z daily 0.75 https://www.medxy.ai/news/redefining-care-scchn 2026-03-02T10:11:20.000Z daily 0.75 https://www.medxy.ai/news/vi/redesigning-care-standards 2026-02-25T21:22:28.000Z daily 0.75 https://www.medxy.ai/news/ja/high-risk-head-and-neck-cancer 2026-02-25T21:22:21.000Z daily 0.75 https://www.medxy.ai/news/zh/redesigning-standard-treatment-scchn 2026-02-25T21:22:06.000Z daily 0.75 https://www.medxy.ai/news/rethinking-standard-frail-elderly 2026-03-02T10:10:24.000Z daily 0.75 https://www.medxy.ai/news/vi/review-standards-cancer-elderly 2026-02-26T09:11:42.000Z daily 0.75 https://www.medxy.ai/news/ja/reconsidering-standards-head-and-neck-cancer 2026-02-26T09:11:52.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-standards-head-neck-cancer 2026-02-26T09:12:02.000Z daily 0.75 https://www.medxy.ai/news/risk-stratification-oligorecurrent-prostate-cancer 2026-03-02T10:10:16.000Z daily 0.75 https://www.medxy.ai/news/vi/prostate-cancer-risk-classification 2026-02-26T09:12:29.000Z daily 0.75 https://www.medxy.ai/news/ja/psma-pet-prostate-cancer-risk 2026-02-26T09:12:41.000Z daily 0.75 https://www.medxy.ai/news/zh/psma-pet-risk-prostate-cancer 2026-02-26T09:12:55.000Z daily 0.75 https://www.medxy.ai/news/mri-guided-chemotherapy 2026-03-02T09:21:41.000Z daily 0.75 https://www.medxy.ai/news/keyvibe-010-tigit-inhibition-failed 2026-03-02T09:21:38.000Z daily 0.75 https://www.medxy.ai/news/vi/tigit-inhibition-pembrolizumab-melanoma 2026-03-02T09:21:36.000Z daily 0.75 https://www.medxy.ai/news/ja/keyvibe-010-tigit-inhibition-2 2026-02-26T09:21:32.000Z daily 0.75 https://www.medxy.ai/news/zh/keyvibe-010-tigit-inhibition 2026-02-26T09:21:45.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-effects-mpox-vs-mva-bn 2026-02-27T11:41:27.000Z daily 0.75 https://www.medxy.ai/news/ja/monkeypox-vaccine-long-term-effects 2026-02-27T11:41:13.000Z daily 0.75 https://www.medxy.ai/news/monkeypox-outcomes-analysis 2026-03-02T09:21:31.000Z daily 0.75 https://www.medxy.ai/news/zh/monkeypox-vaccine-outcomes 2026-02-27T11:39:37.000Z daily 0.75 https://www.medxy.ai/news/glaucoma-behavioral-intervention 2026-03-02T09:21:28.000Z daily 0.75 https://www.medxy.ai/news/vi/glaucoma-management-interventions 2026-02-27T11:39:04.000Z daily 0.75 https://www.medxy.ai/news/ja/glaucoma-management-insights 2026-02-27T11:38:57.000Z daily 0.75 https://www.medxy.ai/news/zh/glaucoma-management-insights-2 2026-02-27T11:38:50.000Z daily 0.75 https://www.medxy.ai/news/optimizing-kit-exon-9-gist 2026-03-02T09:21:24.000Z daily 0.75 https://www.medxy.ai/news/vi/optimal-support-therapy-exon-9-kits 2026-02-27T11:38:21.000Z daily 0.75 https://www.medxy.ai/news/zh/optimized-kit-mutation-treatment 2026-02-27T11:38:05.000Z daily 0.75 https://www.medxy.ai/news/three-year-tislelizumab-survival-benefit 2026-03-02T09:21:18.000Z daily 0.75 https://www.medxy.ai/news/vi/rationale-309-tislelizumab-cancer 2026-02-27T11:12:49.000Z daily 0.75 https://www.medxy.ai/news/ja/rationale-309-nasopharyngeal-cancer 2026-02-27T11:12:30.000Z daily 0.75 https://www.medxy.ai/news/zh/rationale-309-nasopharyngeal-cancer-survival 2026-02-27T11:12:22.000Z daily 0.75 https://www.medxy.ai/news/amivantamab-clinical-benefit 2026-03-02T09:21:15.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-objective-reaction-amivantamab-benefits 2026-02-27T11:12:11.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-objective-response 2026-02-27T11:11:55.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-objective-response-amivantamab 2026-02-27T11:11:47.000Z daily 0.75 https://www.medxy.ai/news/breaking-hardware-barrier-3d-oct-detection 2026-03-02T09:21:11.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-hardware-barriers-ai-oct-disease-detection 2026-02-27T11:37:54.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-hardware-barriers 2026-02-27T11:37:46.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-hardware-barriers-2 2026-02-27T11:37:39.000Z daily 0.75 https://www.medxy.ai/news/long-term-pfo-closure-outcomes 2026-03-02T09:21:08.000Z daily 0.75 https://www.medxy.ai/news/global-patient-radiation-exposure 2026-03-02T09:21:04.000Z daily 0.75 https://www.medxy.ai/news/vi/global-radiation-exposure-cardiac-diagnosis 2026-03-02T09:20:57.000Z daily 0.75 https://www.medxy.ai/news/ja/coronary-disease-radiation-exposure 2026-03-02T09:20:49.000Z daily 0.75 https://www.medxy.ai/news/zh/radiation-exposure-differences 2026-03-02T09:20:44.000Z daily 0.75 https://www.medxy.ai/news/adhd-mapping-biotyping 2026-03-02T09:20:34.000Z daily 0.75 https://www.medxy.ai/news/vi/adhd-diversity-formatting 2026-03-02T09:20:25.000Z daily 0.75 https://www.medxy.ai/news/ja/adhd-heterogeneity-mapping 2026-03-02T09:20:15.000Z daily 0.75 https://www.medxy.ai/news/zh/adhd-heterogeneity-research 2026-03-02T09:20:09.000Z daily 0.75 https://www.medxy.ai/news/rivaroxaban-fails-anterior-stemi 2026-03-02T09:19:56.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-rivaroxaban-stemi 2026-03-02T09:19:53.000Z daily 0.75 https://www.medxy.ai/news/zh/low-dose-rivaroxaban-stemi-results 2026-03-02T09:19:44.000Z daily 0.75 https://www.medxy.ai/news/surgical-management-medullary-thyroid-cancer 2026-03-02T09:19:38.000Z daily 0.75 https://www.medxy.ai/news/vi/thyroid-cancer-surgery-management 2026-03-02T09:19:31.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-cancer-surgery-comparison 2026-03-02T09:19:23.000Z daily 0.75 https://www.medxy.ai/news/zh/surgical-treatment-thyroid-cancer 2026-03-02T09:19:13.000Z daily 0.75 https://www.medxy.ai/news/sex-race-ancestry-amyloid-pathology 2026-03-02T09:18:59.000Z daily 0.75 https://www.medxy.ai/news/vi/sex-race-origin-amyloid 2026-03-02T09:18:55.000Z daily 0.75 https://www.medxy.ai/news/ja/gender-race-ancestry-amiloid 2026-03-02T09:18:44.000Z daily 0.75 https://www.medxy.ai/news/zh/gender-race-pathology 2026-03-02T09:18:34.000Z daily 0.75 https://www.medxy.ai/news/pediatric-outcomes-optimization 2026-03-02T09:18:23.000Z daily 0.75 https://www.medxy.ai/news/vi/optimize-child-results 2026-03-02T09:18:13.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-treatment-optimization 2026-03-02T09:18:01.000Z daily 0.75 https://www.medxy.ai/news/qtc-paradox-stroke-risk 2026-03-02T09:17:52.000Z daily 0.75 https://www.medxy.ai/news/zh/optimizing-pediatric-outcomes 2026-03-02T09:17:48.000Z daily 0.75 https://www.medxy.ai/news/vi/paradox-qt-length 2026-03-02T09:17:27.000Z daily 0.75 https://www.medxy.ai/news/ja/qt-prolongation-paradox 2026-03-02T09:17:17.000Z daily 0.75 https://www.medxy.ai/news/zh/qtc-paradox-low-stroke-risk 2026-03-02T09:17:09.000Z daily 0.75 https://www.medxy.ai/news/digital-health-lit-proctology 2026-03-02T09:17:00.000Z daily 0.75 https://www.medxy.ai/news/vi/digital-health-culture-hemorrhoids 2026-03-02T09:16:54.000Z daily 0.75 https://www.medxy.ai/news/ja/digital-health-literacy 2026-03-02T09:16:49.000Z daily 0.75 https://www.medxy.ai/news/zh/digital-health-literacy-hemorrhoids 2026-03-02T09:16:42.000Z daily 0.75 https://www.medxy.ai/news/voyager-pad-insight-antithrombotic-therapy 2026-03-02T09:16:23.000Z daily 0.75 https://www.medxy.ai/news/vi/voyager-pad-analysis 2026-03-02T09:16:13.000Z daily 0.75 https://www.medxy.ai/news/ja/voyager-pad-insights 2026-03-02T09:16:07.000Z daily 0.75 https://www.medxy.ai/news/zh/voyager-pad-insights-2 2026-03-02T09:15:55.000Z daily 0.75 https://www.medxy.ai/news/nurse-led-care-impact 2026-03-02T09:15:36.000Z daily 0.75 https://www.medxy.ai/news/cardiovascular-disease-forecast 2026-03-02T09:15:25.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiovascular-trends-2050 2026-03-02T09:15:20.000Z daily 0.75 https://www.medxy.ai/news/vi/tsunami-heart-disease-2050 2026-03-02T09:15:11.000Z daily 0.75 https://www.medxy.ai/news/ja/cardiovascular-disease-forecast-2 2026-03-02T09:15:02.000Z daily 0.75 https://www.medxy.ai/news/heart-failure-prevention-diabetes 2026-03-02T09:14:37.000Z daily 0.75 https://www.medxy.ai/news/vi/heart-failure-prevention-diabetes-3 2026-03-02T09:14:31.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-prevention-diabetes-2 2026-03-02T09:14:27.000Z daily 0.75 https://www.medxy.ai/news/zh/type-2-diabetes-heart-failure-prevention 2026-03-02T09:14:22.000Z daily 0.75 https://www.medxy.ai/news/noacs-vs-warfarin-embolic-events 2026-03-02T09:14:12.000Z daily 0.75 https://www.medxy.ai/news/vi/noacs-vs-warfarin-thromboembolism 2026-03-02T09:14:06.000Z daily 0.75 https://www.medxy.ai/news/ja/noac-versus-warfarin-risk 2026-03-02T09:13:59.000Z daily 0.75 https://www.medxy.ai/news/zh/noacs-vs-warfarin-embolism 2026-03-02T09:13:53.000Z daily 0.75 https://www.medxy.ai/news/restrictive-physiology-cardiac-amyloidosis 2026-03-02T09:13:47.000Z daily 0.75 https://www.medxy.ai/news/vi/amyloid-heart-disease-clinical-overview 2026-03-02T09:13:36.000Z daily 0.75 https://www.medxy.ai/news/ja/restricted-physiology-defining-cardiac-amyloidosis 2026-03-02T09:13:32.000Z daily 0.75 https://www.medxy.ai/news/zh/restrictive-physiology-amiloidosis 2026-03-02T09:13:27.000Z daily 0.75 https://www.medxy.ai/news/vi/risk-threshold-women-cad 2026-03-02T09:13:16.000Z daily 0.75 https://www.medxy.ai/news/ja/risk-threshold-cardiac-disease 2026-03-02T09:13:12.000Z daily 0.75 https://www.medxy.ai/news/zh/gender-specific-risk-thresholds 2026-03-02T09:13:06.000Z daily 0.75 https://www.medxy.ai/news/pci-tavr-outcomes 2026-03-02T09:13:00.000Z daily 0.75 https://www.medxy.ai/news/vi/percutaneous-coronary-intervention-tavr 2026-03-02T09:12:55.000Z daily 0.75 https://www.medxy.ai/news/ja/tavr-pre-percutaneous-intervention 2026-03-02T09:12:51.000Z daily 0.75 https://www.medxy.ai/news/zh/percutaneous-coronary-intervention-tavr-analysis 2026-03-02T09:12:45.000Z daily 0.75 https://www.medxy.ai/news/angiographic-coronary-atherosclerosis 2026-03-02T09:12:40.000Z daily 0.75 https://www.medxy.ai/news/vi/angiographic-burden-ascvd 2026-03-02T09:12:37.000Z daily 0.75 https://www.medxy.ai/news/ja/coronary-atherosclerosis-angiography 2026-03-02T09:12:29.000Z daily 0.75 https://www.medxy.ai/news/zh/coronary-atherosclerosis-burden 2026-03-02T09:12:21.000Z daily 0.75 https://www.medxy.ai/news/targeted-hev-modulation 2026-03-02T09:12:12.000Z daily 0.75 https://www.medxy.ai/news/vi/heav-targeted-strategy 2026-03-02T09:12:08.000Z daily 0.75 https://www.medxy.ai/news/ja/targeted-hev-regulation 2026-03-02T09:12:03.000Z daily 0.75 https://www.medxy.ai/news/zh/targeting-hev-regulation 2026-03-02T09:11:56.000Z daily 0.75 https://www.medxy.ai/news/aki-diuretic-resistance 2026-03-02T09:11:43.000Z daily 0.75 https://www.medxy.ai/news/vi/acute-kidney-disease 2026-03-02T09:11:40.000Z daily 0.75 https://www.medxy.ai/news/ja/aki-and-diuretic-resistance 2026-03-02T09:11:37.000Z daily 0.75 https://www.medxy.ai/news/zh/aki-diuretic-resistance-2 2026-03-02T09:11:30.000Z daily 0.75 https://www.medxy.ai/news/serum-metabolomics-af-risk 2026-03-02T09:11:18.000Z daily 0.75 https://www.medxy.ai/news/vi/serum-metabolomics-afib-risk 2026-03-02T09:11:14.000Z daily 0.75 https://www.medxy.ai/news/ja/serum-metabolomics-af-risk-2 2026-03-02T09:11:10.000Z daily 0.75 https://www.medxy.ai/news/zh/serum-metabolomics-afib-prediction 2026-03-02T09:11:06.000Z daily 0.75 https://www.medxy.ai/news/bmpr2-breast-cancer-pulmonary-hypertension 2026-03-02T09:10:44.000Z daily 0.75 https://www.medxy.ai/news/vi/bmpr2-nexus-breast-cancer 2026-03-02T09:10:53.000Z daily 0.75 https://www.medxy.ai/news/ja/bmpr2-role-breast-cancer 2026-03-02T09:10:49.000Z daily 0.75 https://www.medxy.ai/news/zh/bmpr2-intersection-breast-cancer-pulmonary-hypertension 2026-03-02T09:10:57.000Z daily 0.75 https://www.medxy.ai/news/cardiac-repair-cc1-ccr8 2026-03-02T09:10:22.000Z daily 0.75 https://www.medxy.ai/news/vi/heart-repair-coordination 2026-03-02T09:10:17.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-repair-ccl1-ccr8 2026-03-02T09:09:50.000Z daily 0.75 https://www.medxy.ai/news/zh/heart-repair-ccl1-ccr8-2 2026-03-02T09:09:41.000Z daily 0.75 https://www.medxy.ai/news/proteomic-insights-venous-thromboembolism 2026-03-02T09:09:45.000Z daily 0.75 https://www.medxy.ai/news/vi/venous-thrombosis-proteome-expansion 2026-03-02T09:09:27.000Z daily 0.75 https://www.medxy.ai/news/ja/venous-thrombosis-proteomics 2026-03-02T09:09:21.000Z daily 0.75 https://www.medxy.ai/news/zh/venous-thromboembolism-proteomics 2026-03-02T09:09:17.000Z daily 0.75 https://www.medxy.ai/news/obesity-cardiovascular-insights 2026-03-02T09:08:40.000Z daily 0.75 https://www.medxy.ai/news/vi/obesity-cardiac-cooperation 2026-03-02T09:08:23.000Z daily 0.75 https://www.medxy.ai/news/ja/obesity-severity-cardiovascular-insights 2026-03-02T09:08:11.000Z daily 0.75 https://www.medxy.ai/news/zh/obesity-and-cardiovascular-trajectories 2026-03-02T09:08:04.000Z daily 0.75 https://www.medxy.ai/news/targeting-rotational-atherectomy 2026-03-02T09:07:48.000Z daily 0.75 https://www.medxy.ai/news/vi/calcium-atherosclerosis-success 2026-03-02T09:07:45.000Z daily 0.75 https://www.medxy.ai/news/ja/calcium-deposition-success 2026-03-02T09:07:39.000Z daily 0.75 https://www.medxy.ai/news/zh/targeting-strata-why-calcium 2026-03-02T09:07:30.000Z daily 0.75 https://www.medxy.ai/news/warning-signs-acute-kidney-injury 2026-03-01T19:11:46.000Z daily 0.75 https://www.medxy.ai/news/vi/warning-signs-renal-injury 2026-03-02T09:07:24.000Z daily 0.75 https://www.medxy.ai/news/ja/warning-signs-acute-kidney-injury-2 2026-03-02T09:07:19.000Z daily 0.75 https://www.medxy.ai/news/zh/worsening-warning-sca-i-b-phase-acute-kidney-injury 2026-03-02T09:07:11.000Z daily 0.75 https://www.medxy.ai/news/prmt9-heart-recovery 2026-03-02T08:52:27.000Z daily 0.75 https://www.medxy.ai/news/beyond-restrictive-paradigm 2026-03-02T16:34:56.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-limited-models-amyloidosis 2026-03-02T16:33:41.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-limited-paradigms 2026-03-02T16:33:50.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-limits-heart-amyloidosis 2026-03-02T16:34:00.000Z daily 0.75 https://www.medxy.ai/news/apol1-hypertension-targets 2026-03-02T16:34:12.000Z daily 0.75 https://www.medxy.ai/news/vi/apol1-blood-pressure-mechanism 2026-03-02T16:34:15.000Z daily 0.75 https://www.medxy.ai/news/ja/apol1-hypertension-mechanism-2 2026-03-02T16:34:19.000Z daily 0.75 https://www.medxy.ai/news/zh/apol1-hypertension-mechanism 2026-03-02T16:34:24.000Z daily 0.75 https://www.medxy.ai/news/hemodynamic-paradox-tavr 2026-03-02T16:34:30.000Z daily 0.75 https://www.medxy.ai/news/vi/hemodynamic-characteristics-viv-tavr 2026-03-02T16:34:33.000Z daily 0.75 https://www.medxy.ai/news/ja/valve-in-valve-tavr-paradox 2026-03-02T16:34:37.000Z daily 0.75 https://www.medxy.ai/news/zh/viv-tavr-hemodynamics 2026-03-02T16:34:42.000Z daily 0.75 https://www.medxy.ai/news/sustainable-recovery-rvots 2026-03-02T16:35:15.000Z daily 0.75 https://www.medxy.ai/news/glp1-weight-loss-meta-analysis 2026-03-02T16:35:17.000Z daily 0.75 https://www.medxy.ai/news/vi/women-glp1-weight-loss 2026-03-02T16:35:35.000Z daily 0.75 https://www.medxy.ai/news/zh/women-glp-1-weight-loss 2026-03-02T16:36:00.000Z daily 0.75 https://www.medxy.ai/news/diacerein-knee-osteoarthritis 2026-03-02T16:36:28.000Z daily 0.75 https://www.medxy.ai/news/vi/diacerein-ineffective-placebo 2026-03-02T16:36:24.000Z daily 0.75 https://www.medxy.ai/news/ja/knee-osteoarthritis-inflammation-study 2026-03-02T16:36:42.000Z daily 0.75 https://www.medxy.ai/news/zh/dual-vs-placebo-knees 2026-03-02T16:36:50.000Z daily 0.75 https://www.medxy.ai/news/catheter-ablation-edoxaban-stroke-prevention-2 2026-03-02T16:36:53.000Z daily 0.75 https://www.medxy.ai/news/vi/tropicalization-edoxaban-stroke-prevention 2026-03-02T16:36:59.000Z daily 0.75 https://www.medxy.ai/news/ja/catheter-ablation-edoxaban-stroke-prevention 2026-03-02T16:37:07.000Z daily 0.75 https://www.medxy.ai/news/zh/catheter-ablation-and-edoxaban-secondary-stroke-prevention 2026-03-02T16:40:06.000Z daily 0.75 https://www.medxy.ai/news/isolated-coronary-artery-ectasia 2026-03-02T12:05:13.000Z daily 0.75 https://www.medxy.ai/news/low-dose-lithium-cognitive-impairment 2026-03-02T16:37:14.000Z daily 0.75 https://www.medxy.ai/news/plasma-gfap-nfl-brain-injury 2026-03-02T16:37:18.000Z daily 0.75 https://www.medxy.ai/news/vi/plasma-gfap-nfl-predictors 2026-03-02T16:37:29.000Z daily 0.75 https://www.medxy.ai/news/ja/pediatric-ecmo-gfap-nfl 2026-03-02T16:37:37.000Z daily 0.75 https://www.medxy.ai/news/zh/plasma-gfap-nfl-pediatric-ecmo-2 2026-03-02T16:37:42.000Z daily 0.75 https://www.medxy.ai/news/plasma-gfap-nfl-pediatric-ecmo 2026-03-02T16:37:45.000Z daily 0.75 https://www.medxy.ai/news/vi/gfap-nfl-predicts-acl-injury 2026-03-02T16:37:57.000Z daily 0.75 https://www.medxy.ai/news/ja/plasma-gfap-nfl-levels-ecmo 2026-03-02T16:38:06.000Z daily 0.75 https://www.medxy.ai/news/zh/plasma-gfap-nfl-predicts-acute-brain-injury 2026-03-02T16:38:11.000Z daily 0.75 https://www.medxy.ai/news/long-term-prognosis-myocardial-infarction 2026-03-02T16:38:14.000Z daily 0.75 https://www.medxy.ai/news/predicting-fabry-cardio-outcomes 2026-03-02T16:38:16.000Z daily 0.75 https://www.medxy.ai/news/vi/fabry-heart-risk-prediction 2026-03-02T16:38:23.000Z daily 0.75 https://www.medxy.ai/news/ja/fabry-disease-cardiovascular-outlook 2026-03-02T16:38:31.000Z daily 0.75 https://www.medxy.ai/news/zh/fabry-disease-cardiovascular-outcomes 2026-03-02T16:38:42.000Z daily 0.75 https://www.medxy.ai/news/bicuspid-aortic-valve-genetics 2026-03-02T16:38:52.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-complexity-aortic-valve 2026-03-02T16:38:57.000Z daily 0.75 https://www.medxy.ai/news/ja/genetic-complexity-of-bicuspid-aortic-valve 2026-03-02T16:39:01.000Z daily 0.75 https://www.medxy.ai/news/vi/vitamin-d-obesity-reproduction 2026-03-02T16:40:37.000Z daily 0.75 https://www.medxy.ai/news/zh/decoding-aortic-valve-genetics 2026-03-02T16:39:33.000Z daily 0.75 https://www.medxy.ai/news/vi/d-strategy-male-reproductive-disorder 2026-03-02T16:40:27.000Z daily 0.75 https://www.medxy.ai/news/ja/vitamin-d-obesity-reproductive-protection 2026-03-02T16:40:19.000Z daily 0.75 https://www.medxy.ai/news/zh/vitamin-d-obesity-reproductive-health 2026-03-03T12:13:58.000Z daily 0.75 https://www.medxy.ai/news/aldh2-thrombotic-risk 2026-03-03T12:13:43.000Z daily 0.75 https://www.medxy.ai/news/vi/aldh2-rs671-thrombosis-risk 2026-03-03T12:13:38.000Z daily 0.75 https://www.medxy.ai/news/ja/aldh2-rs671-thrombosis-risk-3 2026-03-03T12:13:33.000Z daily 0.75 https://www.medxy.ai/news/zh/aldh2-rs671-thrombosis-risk-2 2026-03-03T12:13:27.000Z daily 0.75 https://www.medxy.ai/news/daily-chlorhexidine-icu 2026-03-02T17:24:52.000Z daily 0.75 https://www.medxy.ai/news/daily-chlorhexidine-icu-2 2026-03-03T12:13:14.000Z daily 0.75 https://www.medxy.ai/news/vi/daily-chlorhexidine-bath-icu 2026-03-03T12:12:59.000Z daily 0.75 https://www.medxy.ai/news/ja/icu-daily-chlorhexidine-bathing 2026-03-03T12:12:49.000Z daily 0.75 https://www.medxy.ai/news/zh/icu-daily-bath-cessation 2026-03-03T12:12:28.000Z daily 0.75 https://www.medxy.ai/news/biopsy-gold-standard-myocarditis 2026-03-02T19:15:28.000Z daily 0.75 https://www.medxy.ai/news/vi/peripheral-blood-biopsy-standards 2026-03-03T12:12:06.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-peripheral-blood 2026-03-03T12:12:01.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-peripheral-blood-2 2026-03-03T12:11:55.000Z daily 0.75 https://www.medxy.ai/news/insulin-resistance-lvad-recovery 2026-03-02T20:30:55.000Z daily 0.75 https://www.medxy.ai/news/vi/insulin-resistance-lowers-heart-recovery 2026-03-03T12:11:47.000Z daily 0.75 https://www.medxy.ai/news/ja/insulin-resistance-heart-recovery 2026-03-03T12:11:39.000Z daily 0.75 https://www.medxy.ai/news/zh/insulin-resistance-heart-recovery-2 2026-03-03T12:11:28.000Z daily 0.75 https://www.medxy.ai/news/tavr-cardiac-risk-analysis 2026-03-02T20:40:24.000Z daily 0.75 https://www.medxy.ai/news/vi/tavr-heart-complications 2026-03-03T12:11:14.000Z daily 0.75 https://www.medxy.ai/news/ja/tavr-heart-complications-analysis 2026-03-03T12:11:10.000Z daily 0.75 https://www.medxy.ai/news/zh/tavr-complications-risk 2026-03-03T12:11:04.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-kidney-protection 2025-11-08T09:48:12.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitors-kidney-protection-9 2026-03-03T12:10:55.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-kidney-protection-8 2026-03-03T12:10:49.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-kidney-protection-7 2026-03-03T12:10:33.000Z daily 0.75 https://www.medxy.ai/news/mitral-regurgitation-hypertrophic-cardiomyopathy 2026-03-03T10:12:22.000Z daily 0.75 https://www.medxy.ai/news/vi/mitral-regurgitation-in-hypertrophic-cardiomyopathy 2026-03-03T12:10:20.000Z daily 0.75 https://www.medxy.ai/news/ja/hypertrophic-cardiomyopathy-mitral-regurgitation 2026-03-03T12:10:15.000Z daily 0.75 https://www.medxy.ai/news/zh/mitral-regurgitation-hypertrophic-cardiomyopathy-2 2026-03-03T12:10:10.000Z daily 0.75 https://www.medxy.ai/news/s-nitrosylated-pkm2-therapy 2026-03-03T12:10:05.000Z daily 0.75 https://www.medxy.ai/news/vi/pkm2-nitrosylation-treatment 2026-03-03T12:09:59.000Z daily 0.75 https://www.medxy.ai/news/ja/s-nitrosylation-pkm2 2026-03-03T12:09:10.000Z daily 0.75 https://www.medxy.ai/news/zh/targeting-s-nitrosylated-pkm2 2026-03-03T12:09:03.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibition-afib-recurrence 2026-03-03T12:08:56.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibition-af-recurrence 2026-03-03T12:08:50.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-af-recurrence 2026-03-03T12:08:46.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-af-recurrence-2 2026-03-03T12:08:39.000Z daily 0.75 https://www.medxy.ai/news/self-expanding-valves-tavr-results 2026-03-03T11:41:54.000Z daily 0.75 https://www.medxy.ai/news/vi/superior-self-expanding-valve-tavr-lyten-trial 2026-03-03T12:08:32.000Z daily 0.75 https://www.medxy.ai/news/ja/self-expanding-valve-vs-balloon 2026-03-03T12:08:27.000Z daily 0.75 https://www.medxy.ai/news/zh/self-expanding-valve-tavr-results 2026-03-03T12:08:21.000Z daily 0.75 https://www.medxy.ai/news/superior-hemodynamics-valves 2026-03-03T11:53:18.000Z daily 0.75 https://www.medxy.ai/news/vi/hemodynamics-improvement-bioprostheses 2026-03-03T12:08:16.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-hemodynamics-lyten-study 2026-03-03T12:08:10.000Z daily 0.75 https://www.medxy.ai/news/zh/self-expanding-valve-lyten-trial 2026-03-03T12:08:05.000Z daily 0.75 https://www.medxy.ai/news/high-repetition-pulse-ablation 2026-03-03T12:06:55.000Z daily 0.75 https://www.medxy.ai/news/ja/frequent-nanosecond-ablation 2026-03-03T12:14:14.000Z daily 0.75 https://www.medxy.ai/news/zh/high-frequency-pulse-ablation-af 2026-03-03T12:14:19.000Z daily 0.75 https://www.medxy.ai/news/vi/af-ablative-treatment-results 2026-03-03T12:14:25.000Z daily 0.75 https://www.medxy.ai/news/mapping-3d-imaging-vt-ablation 2026-03-03T12:15:11.000Z daily 0.75 https://www.medxy.ai/news/vi/labyrinth-3d-modeling 2026-03-05T22:38:38.000Z daily 0.75 https://www.medxy.ai/news/ja/mapping-maps-3d-imaging-vt-ablation 2026-03-05T22:38:15.000Z daily 0.75 https://www.medxy.ai/news/zh/maze-mapping-3d-imaging-vtach-ablation 2026-03-05T22:38:07.000Z daily 0.75 https://www.medxy.ai/news/arvc-risk-stratification 2026-03-03T13:10:29.000Z daily 0.75 https://www.medxy.ai/news/vi/arvc-risk-classification 2026-03-05T22:37:47.000Z daily 0.75 https://www.medxy.ai/news/ja/arvc-risk-classification-2 2026-03-05T22:37:52.000Z daily 0.75 https://www.medxy.ai/news/zh/arvc-risk-stratification-2 2026-03-05T22:37:56.000Z daily 0.75 https://www.medxy.ai/news/dephospho-mgp-heart-failure 2026-03-05T22:37:14.000Z daily 0.75 https://www.medxy.ai/news/vi/dephospho-mgp-heart-failure-2 2026-03-05T22:37:09.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-matrix-gla-protein 2026-03-05T22:37:04.000Z daily 0.75 https://www.medxy.ai/news/zh/dephosphorylated-mgp-fhf-prognosis 2026-03-05T22:36:59.000Z daily 0.75 https://www.medxy.ai/news/acta2-variants-atherosclerosis 2026-03-03T16:10:06.000Z daily 0.75 https://www.medxy.ai/news/vi/acta2-variants-correlation 2026-03-05T22:36:49.000Z daily 0.75 https://www.medxy.ai/news/ja/acta2-mutation-smooth-muscle-stress 2026-03-05T22:36:32.000Z daily 0.75 https://www.medxy.ai/news/zh/acta2-variants-smooth-muscle-link 2026-03-05T22:36:25.000Z daily 0.75 https://www.medxy.ai/news/plant-based-heart-health 2026-03-05T22:36:13.000Z daily 0.75 https://www.medxy.ai/news/vi/plant-based-lifestyle-benefits 2026-03-05T22:36:06.000Z daily 0.75 https://www.medxy.ai/news/ja/plant-lifestyle-genetic-resistance 2026-03-05T22:35:53.000Z daily 0.75 https://www.medxy.ai/news/zh/plant-based-lifestyle-cardiovascular-prevention 2026-03-05T22:35:46.000Z daily 0.75 https://www.medxy.ai/news/mapping-multimorbidity-asthma 2026-03-03T16:51:40.000Z daily 0.75 https://www.medxy.ai/news/vi/multi-disease-mapping-asthma 2026-03-05T22:34:26.000Z daily 0.75 https://www.medxy.ai/news/ja/mapping-severe-asthma-comorbidities 2026-03-05T22:34:17.000Z daily 0.75 https://www.medxy.ai/news/zh/multiple-comorbidities-asthma 2026-03-05T22:34:06.000Z daily 0.75 https://www.medxy.ai/news/precision-dosing-irinotecan 2026-03-04T10:05:43.000Z daily 0.75 https://www.medxy.ai/news/vi/exact-dose-irinotecan-genotype 2026-03-05T22:33:30.000Z daily 0.75 https://www.medxy.ai/news/ja/no-compromise-dosing 2026-03-05T22:33:19.000Z daily 0.75 https://www.medxy.ai/news/zh/itraconazole-dosing-guided-by-ugt1a1 2026-03-05T22:32:58.000Z daily 0.75 https://www.medxy.ai/news/cardiovascular-risk-overestimate-mortality 2026-03-04T10:57:14.000Z daily 0.75 https://www.medxy.ai/news/ja/mexico-adult-cardiovascular-risk 2026-03-05T22:32:36.000Z daily 0.75 https://www.medxy.ai/news/zh/cardiovascular-risk-overestimation 2026-03-05T22:32:29.000Z daily 0.75 https://www.medxy.ai/news/rsv-vaccination-safety-effectiveness 2026-03-04T11:10:15.000Z daily 0.75 https://www.medxy.ai/news/vi/high-efficacy-rsv-vaccine 2026-03-05T22:32:03.000Z daily 0.75 https://www.medxy.ai/news/ja/high-efficacy-rsv-vaccine-3 2026-03-05T22:31:47.000Z daily 0.75 https://www.medxy.ai/news/zh/high-efficacy-rsv-vaccine-2 2026-03-05T22:31:36.000Z daily 0.75 https://www.medxy.ai/news/sure-02-bladder-preservation 2026-03-04T11:31:17.000Z daily 0.75 https://www.medxy.ai/news/vi/sure-02-sacituzumab-pembrolizumab 2026-03-05T22:30:56.000Z daily 0.75 https://www.medxy.ai/news/ja/sure-02-trial-bladder-cancer 2026-03-05T22:30:34.000Z daily 0.75 https://www.medxy.ai/news/zh/sure-02-trial-bladder-preservation 2026-03-05T22:30:20.000Z daily 0.75 https://www.medxy.ai/news/tip-ca-model-cancer-risk 2026-03-04T12:03:09.000Z daily 0.75 https://www.medxy.ai/news/vi/tip-ca-model-cancer-risk-4 2026-03-05T22:29:19.000Z daily 0.75 https://www.medxy.ai/news/ja/tip-ca-model-cancer-risk-3 2026-03-05T22:29:44.000Z daily 0.75 https://www.medxy.ai/news/zh/tip-ca-model-cancer-risk-2 2026-03-05T22:29:56.000Z daily 0.75 https://www.medxy.ai/news/vi/virtual-biopsy-skin-histology 2026-03-05T22:22:55.000Z daily 0.75 https://www.medxy.ai/news/vi/virtual-biopsy-era 2026-03-05T22:22:47.000Z daily 0.75 https://www.medxy.ai/news/ja/virtual-biopsy-era-3 2026-03-05T22:22:40.000Z daily 0.75 https://www.medxy.ai/news/zh/virtual-biopsy-era-2 2026-03-05T22:22:27.000Z daily 0.75 https://www.medxy.ai/news/patient-voice-hidradenitis 2026-03-05T22:22:15.000Z daily 0.75 https://www.medxy.ai/news/vi/patient-voice-hs 2026-03-05T22:22:10.000Z daily 0.75 https://www.medxy.ai/news/ja/hydradenaite-patient-outcomes 2026-03-05T22:22:04.000Z daily 0.75 https://www.medxy.ai/news/zh/hyperhidrosis-patient-reports 2026-03-05T22:21:56.000Z daily 0.75 https://www.medxy.ai/news/lupuslike-manifestations-myelodysplastic-syndromes 2025-11-24T08:18:03.000Z daily 0.75 https://www.medxy.ai/news/ja/janus-kinase-inhibition-hs 2026-03-05T22:21:38.000Z daily 0.75 https://www.medxy.ai/news/vi/janus-kinase-inhibitors-hidradenitis-suppurativa 2026-03-05T22:21:33.000Z daily 0.75 https://www.medxy.ai/news/ja/janus-kinase-inhibitors-sweat-gland-treatment 2026-03-05T22:21:25.000Z daily 0.75 https://www.medxy.ai/news/unorthodox-jak-dosing-alopecia 2026-03-05T10:07:36.000Z daily 0.75 https://www.medxy.ai/news/zh/janus-kinase-inhibitors-axillary-sweat-glands 2026-03-05T22:21:12.000Z daily 0.75 https://www.medxy.ai/news/antenatal-prebiotic-failure-atopic-dermatitis 2026-03-05T10:12:22.000Z daily 0.75 https://www.medxy.ai/news/vi/supplementation-does-not-prevent-eczema-in-high-risk-infants 2026-03-05T22:20:42.000Z daily 0.75 https://www.medxy.ai/news/ja/probiotics-pregnancy-atopic-eczema 2026-03-05T22:20:34.000Z daily 0.75 https://www.medxy.ai/news/zh/probiotics-pregnancy-eczema 2026-03-05T22:20:23.000Z daily 0.75 https://www.medxy.ai/news/baricitinib-vs-azathioprine 2026-03-05T11:02:48.000Z daily 0.75 https://www.medxy.ai/news/vi/baricitinib-vs-azathioprine-3 2026-03-05T22:20:04.000Z daily 0.75 https://www.medxy.ai/news/ja/baricitinib-vs-azathioprine-atopic-dermatitis 2026-03-05T22:19:57.000Z daily 0.75 https://www.medxy.ai/news/bathing-frequency-eczema-severity 2026-03-05T22:19:49.000Z daily 0.75 https://www.medxy.ai/news/zh/baricitinib-vs-azathioprine-2 2026-03-05T22:11:36.000Z daily 0.75 https://www.medxy.ai/news/vi/bath-frequency-eczema-severity 2026-03-05T22:11:27.000Z daily 0.75 https://www.medxy.ai/news/ja/bathing-frequency-and-eczema-severity 2026-03-05T22:11:21.000Z daily 0.75 https://www.medxy.ai/news/zh/bath-frequency-eczema-severity-2 2026-03-05T22:11:12.000Z daily 0.75 https://www.medxy.ai/news/aletekitug-il18-dermatitis 2026-03-05T12:05:15.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-th2-aletekitug-il-18 2026-03-05T22:11:02.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-th2-atopic-dermatitis 2026-03-05T22:10:54.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-th2-il-18-targeting 2026-03-05T22:09:43.000Z daily 0.75 https://www.medxy.ai/news/apremilast-genital-psoriasis 2026-03-05T12:43:27.000Z daily 0.75 https://www.medxy.ai/news/vi/apremilast-genital-dermatitis 2026-03-05T22:09:28.000Z daily 0.75 https://www.medxy.ai/news/ja/apremilast-long-term-efficacy-safety 2026-03-05T22:09:22.000Z daily 0.75 https://www.medxy.ai/news/zh/aposter-long-term-effectiveness-safety 2026-03-05T22:09:08.000Z daily 0.75 https://www.medxy.ai/news/saturated-saline-immersion 2026-03-05T12:54:08.000Z daily 0.75 https://www.medxy.ai/news/eltrekibart-cxcr1-2-trial 2026-03-05T13:54:24.000Z daily 0.75 https://www.medxy.ai/news/vi/cxcr1-2-ligands-eltrekibart 2026-03-05T22:08:43.000Z daily 0.75 https://www.medxy.ai/news/ja/eltrekibart-cxcr1-2-trial-3 2026-03-05T22:08:38.000Z daily 0.75 https://www.medxy.ai/news/zh/eltrekibart-cxcr1-2-trial-2 2026-03-05T22:08:23.000Z daily 0.75 https://www.medxy.ai/news/precision-dosing-secukinumab 2026-03-05T22:08:12.000Z daily 0.75 https://www.medxy.ai/news/vi/secukinumab-dosing-hidradenitis-suppurativa 2026-03-05T22:08:05.000Z daily 0.75 https://www.medxy.ai/news/ja/secukinumab-dosing-insights 2026-03-05T22:08:00.000Z daily 0.75 https://www.medxy.ai/news/zh/sujindan-antibody-hidradenitis 2026-03-05T22:07:44.000Z daily 0.75 https://www.medxy.ai/news/high-dose-vilobelimab-hidradenitis-suppurativa 2026-03-05T14:45:27.000Z daily 0.75 https://www.medxy.ai/news/vi/high-dose-vilobelimab 2026-03-05T22:07:31.000Z daily 0.75 https://www.medxy.ai/news/ja/high-dose-vilobelimab-clinical-effect 2026-03-05T22:07:24.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-primary-endpoint-vilobelimab 2026-03-05T22:04:56.000Z daily 0.75 https://www.medxy.ai/news/pumecitinib-gel-efficacy 2026-03-05T19:39:31.000Z daily 0.75 https://www.medxy.ai/news/vi/gel-pumecitinib-3-efficacy 2026-03-05T22:04:28.000Z daily 0.75 https://www.medxy.ai/news/ja/pumace-tinib-gel-efficacy 2026-03-05T22:04:04.000Z daily 0.75 https://www.medxy.ai/news/zh/pumexetine-gel-efficacy 2026-03-05T22:03:46.000Z daily 0.75 https://www.medxy.ai/news/intermittent-chemotherapy-melanoma 2026-03-05T23:19:42.000Z daily 0.75 https://www.medxy.ai/news/vi/breaking-the-wall 2026-03-06T15:34:27.000Z daily 0.75 https://www.medxy.ai/news/ja/breaking-walls-chemotherapy-resistance 2026-03-06T15:34:37.000Z daily 0.75 https://www.medxy.ai/news/zh/breaking-barriers-intermittent-chemo-melanoma-resistance 2026-03-06T15:34:54.000Z daily 0.75 https://www.medxy.ai/news/bimekizumab-hidradenitis-suppurativa-2 2026-03-06T15:35:05.000Z daily 0.75 https://www.medxy.ai/news/vi/bimekizumab-hidradenitis-suppurativa 2026-03-06T15:36:15.000Z daily 0.75 https://www.medxy.ai/news/ja/bimekizumab-sweat-gland-inflammation 2026-03-06T15:36:22.000Z daily 0.75 https://www.medxy.ai/news/zh/bimekizumab-axillary-hidradenitis 2026-03-06T15:36:27.000Z daily 0.75 https://www.medxy.ai/news/targeted-tolerance-pemphigus 2026-03-06T15:36:34.000Z daily 0.75 https://www.medxy.ai/news/vi/pemphigus-vulgaris-nanocapsules 2026-03-06T15:36:38.000Z daily 0.75 https://www.medxy.ai/news/ja/targeted-tolerance-induction 2026-03-06T15:36:52.000Z daily 0.75 https://www.medxy.ai/news/zh/targeted-tolerance-induction-tpem203 2026-03-06T15:37:02.000Z daily 0.75 https://www.medxy.ai/news/botanical-solution-cinainu 2026-03-06T11:00:50.000Z daily 0.75 https://www.medxy.ai/news/vi/topical-cinainu-hair-loss 2026-03-06T15:37:13.000Z daily 0.75 https://www.medxy.ai/news/ja/local-plant-solution-test 2026-03-06T15:42:39.000Z daily 0.75 https://www.medxy.ai/news/zh/cinainu-efficacy-safety 2026-03-06T15:42:47.000Z daily 0.75 https://www.medxy.ai/news/sopoongsan-chronic-pruritus 2026-03-06T11:48:50.000Z daily 0.75 https://www.medxy.ai/news/vi/sopoongsan-stat1-inhibition 2026-03-06T15:42:55.000Z daily 0.75 https://www.medxy.ai/news/ja/soponsan-stat1-inhibition-itch-relief 2026-03-06T15:44:58.000Z daily 0.75 https://www.medxy.ai/news/zh/songfeng-disperses-chronic-itch 2026-03-06T15:45:04.000Z daily 0.75 https://www.medxy.ai/news/orforglipron-vs-semaglutide 2026-03-06T12:56:18.000Z daily 0.75 https://www.medxy.ai/news/vi/orforglipron-vs-semaglutide-hba1c 2026-03-06T15:45:15.000Z daily 0.75 https://www.medxy.ai/news/ja/orforglipron-vs-semaglutide-2 2026-03-06T15:45:21.000Z daily 0.75 https://www.medxy.ai/news/questioning-hormone-therapy 2026-03-06T13:02:33.000Z daily 0.75 https://www.medxy.ai/news/zh/orforglipron-vs-semaglutide-3 2026-03-06T15:45:29.000Z daily 0.75 https://www.medxy.ai/news/vi/hormone-therapy-prostate-cancer 2026-03-06T15:45:47.000Z daily 0.75 https://www.medxy.ai/news/ja/routine-hormone-therapy-review 2026-03-06T15:46:08.000Z daily 0.75 https://www.medxy.ai/news/zh/questioning-hormone-therapy-2 2026-03-06T15:46:21.000Z daily 0.75 https://www.medxy.ai/news/beyond-dopamine-blocking 2026-03-06T13:10:12.000Z daily 0.75 https://www.medxy.ai/news/comparative-efficacy-antipsychotics 2026-03-06T13:14:33.000Z daily 0.75 https://www.medxy.ai/news/vi/muscarinic-interventions-analysis 2026-03-06T15:46:45.000Z daily 0.75 https://www.medxy.ai/news/ja/antipsychotic-comparison-analysis 2026-03-06T13:19:28.000Z daily 0.75 https://www.medxy.ai/news/zh/antipsychotic-comparison-analysis 2026-03-06T13:21:37.000Z daily 0.75 https://www.medxy.ai/news/cellular-therapy-myelo-repair 2026-03-06T13:24:37.000Z daily 0.75 https://www.medxy.ai/news/patient-centered-outcomes-geriatrics 2026-03-06T15:46:59.000Z daily 0.75 https://www.medxy.ai/news/vi/geriatric-cancer-patient-outcomes 2026-03-06T15:47:04.000Z daily 0.75 https://www.medxy.ai/news/ja/patient-outcomes-elderly-oncology 2026-03-06T15:47:10.000Z daily 0.75 https://www.medxy.ai/news/zh/patient-centered-outcomes 2026-03-06T15:47:15.000Z daily 0.75 https://www.medxy.ai/news/genomic-therapy-rare-cancers 2026-03-06T15:47:23.000Z daily 0.75 https://www.medxy.ai/news/vi/gen-therapy-in-rare-cancers 2026-03-06T15:47:27.000Z daily 0.75 https://www.medxy.ai/news/ja/genome-therapy-matching 2026-03-06T15:47:38.000Z daily 0.75 https://www.medxy.ai/news/zh/genomic-therapy-matching 2026-03-06T15:47:43.000Z daily 0.75 https://www.medxy.ai/news/pharmacotherapy-hypertrophic-cardiomyopathy 2026-03-06T15:47:54.000Z daily 0.75 https://www.medxy.ai/news/vi/drug-therapy-review-hcm 2026-03-06T15:47:58.000Z daily 0.75 https://www.medxy.ai/news/ja/reconsidering-drug-therapy-hypertrophic-cardiomyopathy 2026-03-06T15:48:24.000Z daily 0.75 https://www.medxy.ai/news/zh/revisiting-hypertrophic-cardiomyopathy-treatment 2026-03-06T15:48:29.000Z daily 0.75 https://www.medxy.ai/news/silent-genetic-threat 2026-03-06T15:13:41.000Z daily 0.75 https://www.medxy.ai/news/vi/silent-genetic-threat-2 2026-03-06T15:48:35.000Z daily 0.75 https://www.medxy.ai/news/ja/silent-genetic-threat-3 2026-03-06T15:48:43.000Z daily 0.75 https://www.medxy.ai/news/zh/silent-genetic-threat-4 2026-03-06T15:48:49.000Z daily 0.75 https://www.medxy.ai/news/mutton-hf-indigenous-foods 2026-03-06T15:58:25.000Z daily 0.75 https://www.medxy.ai/news/vi/mutton-hf-food-system-recovery 2026-03-06T15:48:57.000Z daily 0.75 https://www.medxy.ai/news/ja/mutton-hf-indigenous-food-systems-2 2026-03-06T15:49:05.000Z daily 0.75 https://www.medxy.ai/news/zh/mutton-hf-indigenous-food-systems 2026-03-06T15:49:10.000Z daily 0.75 https://www.medxy.ai/news/precision-risk-stratification 2026-03-06T15:58:21.000Z daily 0.75 https://www.medxy.ai/news/vi/cushing-risk-classification 2026-03-06T15:58:00.000Z daily 0.75 https://www.medxy.ai/news/ja/cushing-disease-risk-stratification-2 2026-03-06T15:58:11.000Z daily 0.75 https://www.medxy.ai/news/zh/cushing-disease-risk-stratification 2026-03-06T15:58:17.000Z daily 0.75 https://www.medxy.ai/news/sglt2-inhibitors-gout-relief 2026-03-06T15:57:48.000Z daily 0.75 https://www.medxy.ai/news/vi/sglt2-inhibitor-gout-treatment 2026-03-06T16:31:52.000Z daily 0.75 https://www.medxy.ai/news/ja/sglt2-inhibitors-gout-relief-2 2026-03-06T16:31:39.000Z daily 0.75 https://www.medxy.ai/news/zh/sglt2-inhibitors-gout-burden 2026-03-06T16:31:22.000Z daily 0.75 https://www.medxy.ai/news/oxygen-guided-success 2026-03-06T16:09:07.000Z daily 0.75 https://www.medxy.ai/news/mody-diagnosis-novel-variants 2026-03-06T16:20:22.000Z daily 0.75 https://www.medxy.ai/news/vi/mody-diagnosis-ins-variants 2026-03-06T16:30:44.000Z daily 0.75 https://www.medxy.ai/news/ja/mody-diagnosis-redefined 2026-03-06T16:30:53.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-dosage-deficiency 2026-03-06T16:31:06.000Z daily 0.75 https://www.medxy.ai/news/active-surveillance-thyroid-nodules 2026-03-06T16:30:18.000Z daily 0.75 https://www.medxy.ai/news/vi/active-safety-ras-tumors 2026-03-06T23:03:16.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-surgical-removal 2026-03-06T23:03:01.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-surgical-removal-2 2026-03-06T23:02:48.000Z daily 0.75 https://www.medxy.ai/news/antiepileptogenesis-stroke-eslicarbazepine 2026-03-06T16:40:01.000Z daily 0.75 https://www.medxy.ai/news/vi/stroke-seizure-prevention 2026-03-06T23:02:36.000Z daily 0.75 https://www.medxy.ai/news/ja/stroke-treatment-evaluation 2026-03-06T23:02:29.000Z daily 0.75 https://www.medxy.ai/news/zh/stroke-epilepsy-prevention 2026-03-06T23:02:24.000Z daily 0.75 https://www.medxy.ai/news/rethinking-rhythm-control 2026-03-06T23:02:19.000Z daily 0.75 https://www.medxy.ai/news/vi/heart-rate-control-stroke-prevention 2026-03-06T23:02:12.000Z daily 0.75 https://www.medxy.ai/news/ja/rhythm-control-stroke-prevention 2026-03-06T23:02:08.000Z daily 0.75 https://www.medxy.ai/news/zh/rethinking-heart-rate-control 2026-03-06T23:02:03.000Z daily 0.75 https://www.medxy.ai/news/age-onset-nmosd 2026-03-06T23:01:52.000Z daily 0.75 https://www.medxy.ai/news/vi/age-onset-nmosd-2 2026-03-06T23:01:46.000Z daily 0.75 https://www.medxy.ai/news/ja/aqp4-igg-nmosd-age-clinical-course 2026-03-06T23:01:39.000Z daily 0.75 https://www.medxy.ai/news/zh/aqp4-igg-nmosd-onset-age 2026-03-06T23:01:34.000Z daily 0.75 https://www.medxy.ai/news/genetic-breakthrough-snubn-variants 2026-03-06T23:01:10.000Z daily 0.75 https://www.medxy.ai/news/watchful-waiting-anxiety 2026-03-06T23:01:04.000Z daily 0.75 https://www.medxy.ai/news/vi/psychological-burden-aneurysm-risk 2026-03-06T23:01:02.000Z daily 0.75 https://www.medxy.ai/news/ja/waiting-observation-mental-burden 2026-03-06T23:00:49.000Z daily 0.75 https://www.medxy.ai/news/zh/psychological-burden-observation 2026-03-06T23:00:42.000Z daily 0.75 https://www.medxy.ai/news/stem-cell-therapy-misfire 2026-03-06T23:03:26.000Z daily 0.75 https://www.medxy.ai/news/vi/stem-cell-therapy-failed 2026-03-07T12:00:25.000Z daily 0.75 https://www.medxy.ai/news/ja/stem-cell-therapy-failure 2026-03-07T12:00:43.000Z daily 0.75 https://www.medxy.ai/news/zh/stem-cell-therapy-fistula 2026-03-07T12:00:53.000Z daily 0.75 https://www.medxy.ai/news/goulash-trial-nutrition 2026-03-07T07:12:33.000Z daily 0.75 https://www.medxy.ai/news/vi/not-more-is-better-3 2026-03-07T12:01:35.000Z daily 0.75 https://www.medxy.ai/news/ja/not-more-is-better-4 2026-03-07T12:01:47.000Z daily 0.75 https://www.medxy.ai/news/zh/not-more-is-better-5 2026-03-07T12:01:54.000Z daily 0.75 https://www.medxy.ai/news/optimizing-immunotherapy-cholangiocarcinoma 2026-03-07T12:02:11.000Z daily 0.75 https://www.medxy.ai/news/vi/optimal-immunotherapy-bile-duct-cancer 2026-03-07T12:02:21.000Z daily 0.75 https://www.medxy.ai/news/zh/catalyzing-immunotherapy-in-cholangiocarcinoma 2026-03-07T12:02:38.000Z daily 0.75 https://www.medxy.ai/news/imatinib-kits-exon-9-gist-2 2026-03-07T12:02:43.000Z daily 0.75 https://www.medxy.ai/news/vi/imatinib-kits-exon-9-gist 2026-03-07T12:02:54.000Z daily 0.75 https://www.medxy.ai/news/ja/imatinib-gist-survival-evidence 2026-03-07T12:03:03.000Z daily 0.75 https://www.medxy.ai/news/zh/imatinib-survival-study-gist 2026-03-07T12:03:17.000Z daily 0.75 https://www.medxy.ai/news/scar-evolution-mri-outcomes 2026-03-07T12:03:06.000Z daily 0.75 https://www.medxy.ai/news/beyond-traditional-risk-factors 2026-03-07T12:05:42.000Z daily 0.75 https://www.medxy.ai/news/vi/overcoming-traditional-risk-factors 2026-03-07T12:08:22.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-traditional-risk-factors 2026-03-07T12:10:31.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-traditional-risk-factors 2026-03-07T12:12:24.000Z daily 0.75 https://www.medxy.ai/news/preventive-pci-vulnerable-plaques 2026-03-07T13:19:17.000Z daily 0.75 https://www.medxy.ai/news/vi/pci-for-unrestricted-atherosclerosis 2026-03-07T13:23:11.000Z daily 0.75 https://www.medxy.ai/news/ja/non-flow-limiting-plaques-pci 2026-03-07T13:25:14.000Z daily 0.75 https://www.medxy.ai/news/zh/preventive-pci-non-flow-limiting 2026-03-07T13:27:20.000Z daily 0.75 https://www.medxy.ai/news/beyond-binary-aldosteronism 2026-03-07T14:07:54.000Z daily 0.75 https://www.medxy.ai/news/zh/beyond-binary-aldosteronism-risk 2026-03-07T14:09:49.000Z daily 0.75 https://www.medxy.ai/news/vi/outside-binary-aldosterone-risk 2026-03-07T14:12:02.000Z daily 0.75 https://www.medxy.ai/news/ja/beyond-binarity-aldosterone-risk 2026-03-07T14:14:48.000Z daily 0.75 https://www.medxy.ai/news/prevalence-restriction-systolic-dysfunction 2026-03-07T17:28:20.000Z daily 0.75 https://www.medxy.ai/news/synergistic-protection-glp1-lifestyle 2026-03-07T17:29:35.000Z daily 0.75 https://www.medxy.ai/news/vi/protecting-health-glp-1 2026-03-07T17:33:21.000Z daily 0.75 https://www.medxy.ai/news/ja/coordinated-protection-glp-1 2026-03-07T17:35:10.000Z daily 0.75 https://www.medxy.ai/news/zh/collaborative-protection-glp1 2026-03-07T17:37:26.000Z daily 0.75 https://www.medxy.ai/news/renal-function-dka-risk 2026-03-07T17:38:51.000Z daily 0.75 https://www.medxy.ai/news/vi/renal-function-risk-dka 2026-03-07T17:43:28.000Z daily 0.75 https://www.medxy.ai/news/ja/kidney-function-metabolism-risk 2026-03-07T17:45:18.000Z daily 0.75 https://www.medxy.ai/news/zh/kidney-function-metabolic-risk 2026-03-07T17:46:46.000Z daily 0.75 https://www.medxy.ai/news/24-vs-12-week-triptorelin 2026-03-07T19:15:31.000Z daily 0.75 https://www.medxy.ai/news/vi/triptorelin-24-vs-12-weeks 2026-03-07T19:17:57.000Z daily 0.75 https://www.medxy.ai/news/ja/triptoledin-dosing-comparison 2026-03-07T19:20:53.000Z daily 0.75 https://www.medxy.ai/news/zh/24-12-week-triporelin 2026-03-07T19:23:10.000Z daily 0.75 https://www.medxy.ai/news/deciphering-znt8a-autoantibodies 2026-03-07T19:00:34.000Z daily 0.75 https://www.medxy.ai/news/vi/decode-znt8a-diabetes-risk 2026-03-07T19:03:16.000Z daily 0.75 https://www.medxy.ai/news/ja/znt8a-and-type-1-diabetes 2026-03-07T19:05:47.000Z daily 0.75 https://www.medxy.ai/news/zh/znt8a-insulin-antibodies 2026-03-07T19:08:08.000Z daily 0.75 https://www.medxy.ai/news/thyroid-ultrasound-risk-stratification 2026-03-08T08:40:09.000Z daily 0.75 https://www.medxy.ai/news/vi/ultrasound-risk-classification 2026-03-08T08:43:03.000Z daily 0.75 https://www.medxy.ai/news/ja/thyroid-ultrasound-risk-assessment 2026-03-08T08:44:49.000Z daily 0.75 https://www.medxy.ai/news/zh/global-thyroid-ultrasound-risk-assessment 2026-03-08T08:45:43.000Z daily 0.75 https://www.medxy.ai/news/fordadistrogene-fails-duchenne-trial 2026-03-08T09:19:08.000Z daily 0.75 https://www.medxy.ai/news/vi/fordadistrogene-movaparvovec-duchenne 2026-03-08T11:25:16.000Z daily 0.75 https://www.medxy.ai/news/ja/duchenne-muscular-dystrophy-outcomes 2026-03-08T11:25:10.000Z daily 0.75 https://www.medxy.ai/news/zh/fordadistrogene-movaparvovec-dupuytrens-disease 2026-03-08T11:25:03.000Z daily 0.75 https://www.medxy.ai/news/low-dose-lithium-cognitive-impairment-2 2026-03-08T11:24:44.000Z daily 0.75 https://www.medxy.ai/news/vi/low-dose-lithium-cognitive-disorder 2026-03-08T11:24:53.000Z daily 0.75 https://www.medxy.ai/news/genomic-landscape-ms 2026-03-08T11:24:35.000Z daily 0.75 https://www.medxy.ai/news/zh/low-dose-lithium-cognitive-disorder-2 2026-03-08T11:24:24.000Z daily 0.75 https://www.medxy.ai/news/vi/ms-research-landscape-mapping 2026-03-08T11:24:07.000Z daily 0.75 https://www.medxy.ai/news/ja/ms-genome-map-insights 2026-03-08T11:23:57.000Z daily 0.75 https://www.medxy.ai/news/zh/multiple-sclerosis-genetics 2026-03-08T11:23:44.000Z daily 0.75 https://www.medxy.ai/news/scrotal-health-guide 2026-03-08T11:05:22.000Z daily 0.75 https://www.medxy.ai/news/vi/testicle-health-guide 2026-03-08T11:23:26.000Z daily 0.75 https://www.medxy.ai/news/ja/scrotum-health-guide 2026-03-08T11:23:19.000Z daily 0.75 https://www.medxy.ai/news/treatment-evolution-5q-sma 2026-03-08T11:23:02.000Z daily 0.75 https://www.medxy.ai/news/vi/treatment-process-atrophia-5q 2026-03-08T19:13:46.000Z daily 0.75 https://www.medxy.ai/news/ja/5q-sma-treatment-evolution-2 2026-03-08T19:13:51.000Z daily 0.75 https://www.medxy.ai/news/zh/5q-sma-treatment-evolution 2026-03-08T19:13:57.000Z daily 0.75 https://www.medxy.ai/news/minimally-invasive-endoscopic-techniques 2026-03-08T11:19:38.000Z daily 0.75 https://www.medxy.ai/news/vi/minimally-invasive-endoscopy 2026-03-08T19:14:07.000Z daily 0.75 https://www.medxy.ai/news/ja/minimally-invasive-neuroplex-recovery 2026-03-08T19:14:22.000Z daily 0.75 https://www.medxy.ai/news/zh/endoscopic-nerve-management 2026-03-08T19:14:34.000Z daily 0.75 https://www.medxy.ai/news/therapeutic-blood-derivatives 2026-03-08T19:14:47.000Z daily 0.75 https://www.medxy.ai/news/vi/potential-blood-products-therapy 2026-03-08T19:14:53.000Z daily 0.75 https://www.medxy.ai/news/ja/self-derived-blood-therapy 2026-03-08T19:14:57.000Z daily 0.75 https://www.medxy.ai/news/zh/autologous-blood-derivatives-research 2026-03-08T19:15:03.000Z daily 0.75 https://www.medxy.ai/news/differential-pathophysiology-angiopathy 2026-03-08T19:15:18.000Z daily 0.75 https://www.medxy.ai/news/vi/disease-role-vascular-space 2026-03-08T19:15:24.000Z daily 0.75 https://www.medxy.ai/news/ja/cerebral-vasculopathy-biomarkers 2026-03-08T19:15:30.000Z daily 0.75 https://www.medxy.ai/news/zh/half-oval-perivascular-spaces 2026-03-08T19:15:34.000Z daily 0.75 https://www.medxy.ai/news/tryptophan-tug-of-war 2026-03-08T15:27:30.000Z daily 0.75 https://www.medxy.ai/news/vi/tryptophan-war-colon-cancer 2026-03-08T19:15:43.000Z daily 0.75 https://www.medxy.ai/news/ja/tryptophan-interaction-colon-cancer 2026-03-08T19:15:51.000Z daily 0.75 https://www.medxy.ai/news/zh/tryptophan-battle-colon-cancer 2026-03-08T19:16:01.000Z daily 0.75 https://www.medxy.ai/news/bemnifosbuvir-hepatitis-e-inhibition 2026-03-08T19:16:11.000Z daily 0.75 https://www.medxy.ai/news/vi/bemnifosbuvir-hepatitis-e-2 2026-03-08T19:16:14.000Z daily 0.75 https://www.medxy.ai/news/ja/bemnifosbuvir-hepatitis-e 2026-03-08T19:16:28.000Z daily 0.75 https://www.medxy.ai/news/zh/beninaprevir-hcv-suppression 2026-03-08T19:16:37.000Z daily 0.75 https://www.medxy.ai/news/unmasking-dars1 2026-03-08T17:10:45.000Z daily 0.75 https://www.medxy.ai/news/vi/dars1-in-liver-cancer 2026-03-08T19:16:47.000Z daily 0.75 https://www.medxy.ai/news/ja/dars1-masks-revealed 2026-03-08T19:16:53.000Z daily 0.75 https://www.medxy.ai/news/zh/dars1-saga-myc-mechanism 2026-03-08T19:17:02.000Z daily 0.75 https://www.medxy.ai/news/long-term-tislelizumab-survival 2026-03-09T10:43:57.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-survival-tislelizumab 2026-03-09T15:41:25.000Z daily 0.75 https://www.medxy.ai/news/ja/tislelizumab-long-term-survival 2026-03-09T15:41:11.000Z daily 0.75 https://www.medxy.ai/news/zh/treatment-benefits-nasopharyngeal-cancer 2026-03-09T15:41:01.000Z daily 0.75 https://www.medxy.ai/news/genotype-phenotype-divergence 2026-03-09T15:40:47.000Z daily 0.75 https://www.medxy.ai/news/vi/genetic-phenotypic-divergence 2026-03-09T15:40:38.000Z daily 0.75 https://www.medxy.ai/news/ja/hypertrophic-cardiomyopathy-genotype-phenotype 2026-03-09T15:40:32.000Z daily 0.75 https://www.medxy.ai/news/zh/hypertrophic-cardiomyopathy-genotype-phenotype-2 2026-03-09T15:40:27.000Z daily 0.75 https://www.medxy.ai/news/long-term-intravascular-imaging-results 2026-03-09T15:40:22.000Z daily 0.75 https://www.medxy.ai/news/vi/long-term-optimization-intracardiac-images 2026-03-09T15:40:17.000Z daily 0.75 https://www.medxy.ai/news/ja/long-term-advantages-vascular-imaging 2026-03-09T15:40:06.000Z daily 0.75 https://www.medxy.ai/news/zh/long-term-benefits-vascular-imaging 2026-03-09T15:39:54.000Z daily 0.75 https://www.medxy.ai/news/inhibiting-myelid-plexind1-atherosclerosis 2026-03-09T11:13:24.000Z daily 0.75 https://www.medxy.ai/news/vi/myeloid-plexind1-strategy 2026-03-09T15:39:46.000Z daily 0.75 https://www.medxy.ai/news/ja/bone-marrow-cells-inhibition 2026-03-09T15:39:27.000Z daily 0.75 https://www.medxy.ai/news/zh/suppress-plexind1-atherosclerosis-strategy 2026-03-09T15:39:21.000Z daily 0.75 https://www.medxy.ai/news/long-term-pfo-closure-study 2026-03-09T11:39:39.000Z daily 0.75 https://www.medxy.ai/news/precision-prediction-heart-failure 2026-03-09T15:39:13.000Z daily 0.75 https://www.medxy.ai/news/vi/accurate-prediction-heart-failure-ai 2026-03-09T15:39:06.000Z daily 0.75 https://www.medxy.ai/news/ja/heart-failure-prediction-ai-ecg 2026-03-09T15:39:00.000Z daily 0.75 https://www.medxy.ai/news/zh/precise-heart-failure-ai 2026-03-09T15:38:54.000Z daily 0.75